BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 028725
(205 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 100 bits (250), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 62/171 (36%), Positives = 96/171 (56%), Gaps = 13/171 (7%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMH 69
+YR L +LEEATNNFD +G G G++Y+G L++G +A++ + S F
Sbjct: 26 SYRV-PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 70 HIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW--QSLT 127
IE +S RH HLVS +G C E + + LI++Y+ NG L+ + G S++
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDE-------RNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 128 WTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
W QR+ IG ARG+ +LHT + ++K +ILLD+N V KI+ + +
Sbjct: 138 WEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 100 bits (250), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 62/171 (36%), Positives = 96/171 (56%), Gaps = 13/171 (7%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMH 69
+YR L +LEEATNNFD +G G G++Y+G L++G +A++ + S F
Sbjct: 26 SYRV-PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 70 HIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW--QSLT 127
IE +S RH HLVS +G C E + + LI++Y+ NG L+ + G S++
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDE-------RNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 128 WTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
W QR+ IG ARG+ +LHT + ++K +ILLD+N V KI+ + +
Sbjct: 138 WEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 97.1 bits (240), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 97/194 (50%), Gaps = 19/194 (9%)
Query: 12 RTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTR-NFMHH 70
+ FSL EL+ A++NF +G G G++Y+GRL +GT +A++ LK ++ F
Sbjct: 26 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 71 IELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI--SGHAWQSLTW 128
+E+IS H +L+ G C + + L++ Y+ NG++ S + + L W
Sbjct: 86 VEMISMAVHRNLLRLRGFCM-------TPTERLLVYPYMANGSVASCLRERPESQPPLDW 138
Query: 129 TQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK- 187
+R A+G ARG+ +LH P + ++K +ILLD+ A + + L L + +
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH 198
Query: 188 --------VGHVTP 193
+GH+ P
Sbjct: 199 VXXAVRGTIGHIAP 212
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 95.1 bits (235), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 19/198 (9%)
Query: 8 LPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTR-N 66
L + FSL EL+ A++NF +G G G++Y+GRL +G +A++ LK +++
Sbjct: 14 LGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ 73
Query: 67 FMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI--SGHAWQ 124
F +E+IS H +L+ G C + + L++ Y+ NG++ S + +
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCM-------TPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 125 SLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 184
L W +R A+G ARG+ +LH P + ++K +ILLD+ A + + L L +
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 185 AE---------KVGHVTP 193
+ +GH+ P
Sbjct: 187 KDXHVXXAVRGXIGHIAP 204
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 79.7 bits (195), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/184 (33%), Positives = 91/184 (49%), Gaps = 22/184 (11%)
Query: 11 YRTFSLEELEEATNNFDTSAF------MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHST 64
+ +FS EL+ TNNFD MGEG G +Y+G + N T +A++ L +T
Sbjct: 6 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITT 64
Query: 65 ----RNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISG 120
+ F I++++K +H +LV LG F DD + L++ Y+PNG+L +S
Sbjct: 65 EELKQQFDQEIKVMAKCQHENLVELLG--FSSDGDD-----LCLVYVYMPNGSLLDRLSC 117
Query: 121 -HAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 179
L+W R A G A GI FLH ++K +ILLD+ AKIS + L
Sbjct: 118 LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 174
Query: 180 LLAE 183
+E
Sbjct: 175 RASE 178
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 79.3 bits (194), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/184 (33%), Positives = 91/184 (49%), Gaps = 22/184 (11%)
Query: 11 YRTFSLEELEEATNNFDTSAF------MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHST 64
+ +FS EL+ TNNFD MGEG G +Y+G + N T +A++ L +T
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITT 70
Query: 65 ----RNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISG 120
+ F I++++K +H +LV LG F DD + L++ Y+PNG+L +S
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLG--FSSDGDD-----LCLVYVYMPNGSLLDRLSC 123
Query: 121 -HAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 179
L+W R A G A GI FLH ++K +ILLD+ AKIS + L
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 180 LLAE 183
+E
Sbjct: 181 RASE 184
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 79.3 bits (194), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/184 (33%), Positives = 91/184 (49%), Gaps = 22/184 (11%)
Query: 11 YRTFSLEELEEATNNFDTSAF------MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHST 64
+ +FS EL+ TNNFD MGEG G +Y+G + N T +A++ L +T
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITT 70
Query: 65 ----RNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISG 120
+ F I++++K +H +LV LG F DD + L++ Y+PNG+L +S
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLG--FSSDGDD-----LCLVYVYMPNGSLLDRLSC 123
Query: 121 -HAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 179
L+W R A G A GI FLH ++K +ILLD+ AKIS + L
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 180 LLAE 183
+E
Sbjct: 181 RASE 184
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 75.5 bits (184), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 60/184 (32%), Positives = 88/184 (47%), Gaps = 22/184 (11%)
Query: 11 YRTFSLEELEEATNNFDTSAF------MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHST 64
+ +FS EL+ TNNFD GEG G +Y+G + N T +A++ L +T
Sbjct: 3 FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITT 61
Query: 65 ----RNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISG 120
+ F I++ +K +H +LV LG F DD + L++ Y PNG+L +S
Sbjct: 62 EELKQQFDQEIKVXAKCQHENLVELLG--FSSDGDD-----LCLVYVYXPNGSLLDRLSC 114
Query: 121 -HAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 179
L+W R A G A GI FLH ++K +ILLD+ AKIS + L
Sbjct: 115 LDGTPPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 171
Query: 180 LLAE 183
+E
Sbjct: 172 RASE 175
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 60.8 bits (146), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 78 -LYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 60.8 bits (146), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 78 -LYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 60.5 bits (145), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 70
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 71 -LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 126
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 127 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 161
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 60.5 bits (145), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G L ++ G + L Q + A +A G+ ++
Sbjct: 78 -LYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 60.1 bits (144), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 78 -LYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 60.1 bits (144), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 68
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 69 -LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 124
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 125 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 159
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 60.1 bits (144), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 66
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 67 -LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 122
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 123 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 157
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 60.1 bits (144), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 78 -LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 60.1 bits (144), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 251 --------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 299
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 60.1 bits (144), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 251 --------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 299
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 59.7 bits (143), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 334 --------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 382
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 59.7 bits (143), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G L ++ G + L Q + A +A G+ ++
Sbjct: 78 -LYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 59.3 bits (142), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 251 --------EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 299
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ K+RH LV
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQ------- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 78 -LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 168
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 78 -LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L +IL+ +NLV K++ + L L E+ E
Sbjct: 134 NYVHRDLAAANILVGENLVCKVADFGLARLIEDNE 168
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 58.5 bits (140), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 4 GALGLPAYRTF-SLEELEEATN------------NFDTSAFMGEGSKGQMYRGRLK---- 46
G L LP RTF E+ T N +G G G++ GRLK
Sbjct: 12 GHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK 71
Query: 47 NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
+AI+ LK+ + R +F+ ++ + H +++ G + + ++
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-------TKSKPVMIV 124
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EY+ NG+L S++ H Q T Q + G+A G+++L G +L +IL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILI 180
Query: 166 DQNLVAKISSYNLPLLAENAEKVGHVT 192
+ NLV K+S + L + E+ + + T
Sbjct: 181 NSNLVCKVSDFGLARVLEDDPEAAYTT 207
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 58.5 bits (140), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 67
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I ++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 68 -LYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 123
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 124 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 158
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 58.5 bits (140), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 4 GALGLPAYRTF-SLEELEEATN------------NFDTSAFMGEGSKGQMYRGRLK---- 46
G L LP RTF E+ T N +G G G++ GRLK
Sbjct: 12 GHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK 71
Query: 47 NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
+AI+ LK+ + R +F+ ++ + H +++ G + + ++
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-------TKSKPVMIV 124
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EY+ NG+L S++ H Q T Q + G+A G+++L G +L +IL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GFVHRDLAARNILI 180
Query: 166 DQNLVAKISSYNLPLLAENAEKVGHVT 192
+ NLV K+S + L + E+ + + T
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 58.5 bits (140), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV E
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
I+++ EY+ G+L ++ G + L Q + A +A G+ ++
Sbjct: 252 --------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 300
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 301 NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNE 335
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 58.5 bits (140), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 4 GALGLPAYRTF-SLEELEEATN------------NFDTSAFMGEGSKGQMYRGRLK---- 46
G L LP RTF E+ T N +G G G++ GRLK
Sbjct: 12 GHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK 71
Query: 47 NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
+AI+ LK+ + R +F+ ++ + H +++ G + + ++
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-------TKSKPVMIV 124
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EY+ NG+L S++ H Q T Q + G+A G+++L G +L +IL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILI 180
Query: 166 DQNLVAKISSYNLPLLAENAEKVGHVT 192
+ NLV K+S + L + E+ + + T
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 58.5 bits (140), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 74
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + + +A G+ ++
Sbjct: 75 -LYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM--- 130
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 165
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 58.5 bits (140), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G+G G+++ G T +AI+ LK + S F+ +++ KLRH LV
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 74
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ S I+++ EY+ G+L ++ G + L Q + + +A G+ ++
Sbjct: 75 -LYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM--- 130
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 165
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 58.5 bits (140), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 4 GALGLPAYRTF-----------SLEEL--EEATNNFDTSAFMGEGSKGQMYRGRLK---- 46
G L LP RTF ++ E E N +G G G++ GRLK
Sbjct: 12 GHLKLPGLRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK 71
Query: 47 NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
+AI+ LK+ + R +F+ ++ + H +++ G + + ++
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-------TKSKPVMIV 124
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EY+ NG+L S++ H Q T Q + G+A G+++L G +L +IL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILI 180
Query: 166 DQNLVAKISSYNLPLLAENAEKVGHVT 192
+ NLV K+S + L + E+ + + T
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 58.2 bits (139), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 4 GALGLPAYRTF-SLEELEEATN------------NFDTSAFMGEGSKGQMYRGRLK---- 46
G L LP RTF E+ T N +G G G++ GRLK
Sbjct: 12 GHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK 71
Query: 47 NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
+AI+ LK+ + R +F+ ++ + H +++ G + + ++
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-------TKSKPVMIV 124
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EY+ NG+L S++ H Q T Q + G+A G+++L G +L +IL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILI 180
Query: 166 DQNLVAKISSYNLPLLAENAEKVGHVT 192
+ NLV K+S + L + E+ + + T
Sbjct: 181 NSNLVCKVSDFGLGRVLEDDPEAAYTT 207
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 57.4 bits (137), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 4 GALGLPAYRTF-SLEELEEATN------------NFDTSAFMGEGSKGQMYRGRLK---- 46
G L LP RT+ E+ T N +G G G++ GRLK
Sbjct: 12 GHLKLPGLRTYVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK 71
Query: 47 NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
+AI+ LK+ + R +F+ ++ + H +++ G + + ++
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-------TKSKPVMIV 124
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EY+ NG+L S++ H Q T Q + G+A G+++L G +L +IL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILI 180
Query: 166 DQNLVAKISSYNLPLLAENAEKVGHVT 192
+ NLV K+S + L + E+ + + T
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 57.0 bits (136), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 4 GALGLPAYRTF-----------SLEEL--EEATNNFDTSAFMGEGSKGQMYRGRLK---- 46
G L LP RT+ ++ E E N +G G G++ GRLK
Sbjct: 12 GHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK 71
Query: 47 NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
+AI+ LK+ + R +F+ ++ + H +++ G + + ++
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-------TKSKPVMIV 124
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EY+ NG+L S++ H Q T Q + G+A G+++L G +L +IL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILI 180
Query: 166 DQNLVAKISSYNLPLLAENAEKVGHVT 192
+ NLV K+S + L + E+ + + T
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 57.0 bits (136), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 4 GALGLPAYRTF-----------SLEEL--EEATNNFDTSAFMGEGSKGQMYRGRLK---- 46
G L LP RT+ ++ E E N +G G G++ GRLK
Sbjct: 10 GHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK 69
Query: 47 NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
+AI+ LK+ + R +F+ ++ + H +++ G + + ++
Sbjct: 70 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-------TKSKPVMIV 122
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EY+ NG+L S++ H Q T Q + G+A G+++L G +L +IL+
Sbjct: 123 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILI 178
Query: 166 DQNLVAKISSYNLPLLAENAEKVGHVT 192
+ NLV K+S + L + E+ + + T
Sbjct: 179 NSNLVCKVSDFGLSRVLEDDPEAAYTT 205
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 4 GALGLPAYRTF-SLEELEEATN------------NFDTSAFMGEGSKGQMYRGRLK---- 46
G L LP RTF E+ T N +G G G++ GRLK
Sbjct: 12 GHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK 71
Query: 47 NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
+AI+ LK+ + R +F+ ++ + H +++ G + + ++
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-------TKSKPVMIV 124
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
E + NG+L S++ H Q T Q + G+A G+++L G +L +IL+
Sbjct: 125 TEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GAVHRDLAARNILI 180
Query: 166 DQNLVAKISSYNLPLLAENAEKVGHVT 192
+ NLV K+S + L + E+ + + T
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 43/178 (24%), Positives = 81/178 (45%), Gaps = 16/178 (8%)
Query: 20 EEATNNFDTSAFMGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSHSTR-NFMHHIELI 74
E N +G G G++ GRLK +AI+ LK+ + R +F+ ++
Sbjct: 29 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 75 SKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISA 134
+ H +++ G + + ++ EY+ NG+L S++ H Q T Q +
Sbjct: 89 GQFDHPNIIRLEGVV-------TKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGM 140
Query: 135 AIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVT 192
G+A G+++L G +L +IL++ NLV K+S + L + E+ + + T
Sbjct: 141 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 195
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 43/178 (24%), Positives = 81/178 (45%), Gaps = 16/178 (8%)
Query: 20 EEATNNFDTSAFMGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSHSTR-NFMHHIELI 74
E N +G G G++ GRLK +AI+ LK+ + R +F+ ++
Sbjct: 12 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 75 SKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISA 134
+ H +++ G + + ++ EY+ NG+L S++ H Q T Q +
Sbjct: 72 GQFDHPNIIRLEGVV-------TKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGM 123
Query: 135 AIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVT 192
G+A G+++L G +L +IL++ NLV K+S + L + E+ + + T
Sbjct: 124 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/150 (26%), Positives = 76/150 (50%), Gaps = 12/150 (8%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTR--NFMHHIELISKLRHCHLVSALGHC 89
+G GS G ++R +G+ +A++ L + H+ R F+ + ++ +LRH ++V +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 90 FECYFDDSSVSRIFLIFEYVPNGTL-RSWISGHAWQSLTWTQRISAAIGVARGIQFLHTG 148
+ + ++ EY+ G+L R A + L +R+S A VA+G+ +LH
Sbjct: 104 -------TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 149 IVPGVFSNNLKITDILLDQNLVAKISSYNL 178
P + NLK ++L+D+ K+ + L
Sbjct: 157 -NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 54.3 bits (129), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 76/150 (50%), Gaps = 12/150 (8%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTR--NFMHHIELISKLRHCHLVSALGHC 89
+G GS G ++R +G+ +A++ L + H+ R F+ + ++ +LRH ++V +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 90 FECYFDDSSVSRIFLIFEYVPNGTL-RSWISGHAWQSLTWTQRISAAIGVARGIQFLHTG 148
+ + ++ EY+ G+L R A + L +R+S A VA+G+ +LH
Sbjct: 104 -------TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 149 IVPGVFSNNLKITDILLDQNLVAKISSYNL 178
P + +LK ++L+D+ K+ + L
Sbjct: 157 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGL 185
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 4 GALGLPAYRTF-----------SLEEL--EEATNNFDTSAFMGEGSKGQMYRGRLK---- 46
G L LP RT+ ++ E E N +G G G++ GRLK
Sbjct: 12 GHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK 71
Query: 47 NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
+AI+ LK+ + R +F+ ++ + H +++ G + + ++
Sbjct: 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-------TKSKPVMIV 124
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
E + NG+L S++ H Q T Q + G+A G+++L G +L +IL+
Sbjct: 125 TEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILI 180
Query: 166 DQNLVAKISSYNLPLLAENAEKVGHVT 192
+ NLV K+S + L + E+ + + T
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 78 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+AE
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAE 163
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 53.5 bits (127), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 12/133 (9%)
Query: 47 NGTFIAIRCLKMKKSHSTRN-FMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
G +A++ LK R+ + I+++ L H H++ G C +D+ + + L+
Sbjct: 59 TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCC-----EDAGAASLQLV 113
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EYVP G+LR ++ H S+ Q + A + G+ +LH +L ++LL
Sbjct: 114 MEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLL 167
Query: 166 DQNLVAKISSYNL 178
D + + KI + L
Sbjct: 168 DNDRLVKIGDFGL 180
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 29/174 (16%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHST----RNFMHHIELISKL-R 78
N+ +GEG+ GQ+ + R+K +K K +++ R+F +E++ KL
Sbjct: 22 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW--------------ISGHAWQ 124
H ++++ LG C ++L EY P+G L + I+
Sbjct: 82 HPNIINLLGAC-------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 134
Query: 125 SLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L+ Q + A VARG+ +L NL +IL+ +N VAKI+ + L
Sbjct: 135 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGL 185
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R KN FI A++ L +++K+ +E+ S L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF DS +R++LI EY P GT L+ ++ T+ ++
Sbjct: 66 RHPNILRLYG-----YFHDS--TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 119 NALSYCHSKKVIHRDIKPENLLLGSAGELKIAD 151
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 73
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 74 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 124
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
NL+ +IL+ L KI+ + L L E+ E
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE 159
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 35/133 (26%), Positives = 62/133 (46%), Gaps = 12/133 (9%)
Query: 47 NGTFIAIRCLKMKKSHSTRN-FMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
G +A++ LK R+ + I+++ L H H++ G C +D + L+
Sbjct: 42 TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCC-----EDQGEKSLQLV 96
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EYVP G+LR ++ H S+ Q + A + G+ +LH+ NL ++LL
Sbjct: 97 MEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLL 150
Query: 166 DQNLVAKISSYNL 178
D + + KI + L
Sbjct: 151 DNDRLVKIGDFGL 163
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/178 (23%), Positives = 80/178 (44%), Gaps = 16/178 (8%)
Query: 20 EEATNNFDTSAFMGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSHSTR-NFMHHIELI 74
E N +G G G++ GRLK +AI+ LK+ + R +F+ ++
Sbjct: 12 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 75 SKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISA 134
+ H +++ G + + ++ E + NG+L S++ H Q T Q +
Sbjct: 72 GQFDHPNIIRLEGVV-------TKSKPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGM 123
Query: 135 AIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVT 192
G+A G+++L G +L +IL++ NLV K+S + L + E+ + + T
Sbjct: 124 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 178
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 47 NGTFIAIRCLKMKKSHSTRN-FMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
G +A++ LK R+ + I+++ L H H++ G C +D + L+
Sbjct: 42 TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCC-----EDQGEKSLQLV 96
Query: 106 FEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILL 165
EYVP G+LR ++ H S+ Q + A + G+ +LH NL ++LL
Sbjct: 97 MEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLL 150
Query: 166 DQNLVAKISSYNL 178
D + + KI + L
Sbjct: 151 DNDRLVKIGDFGL 163
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 29/174 (16%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHST----RNFMHHIELISKL-R 78
N+ +GEG+ GQ+ + R+K +K K +++ R+F +E++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW--------------ISGHAWQ 124
H ++++ LG C ++L EY P+G L + I+
Sbjct: 85 HPNIINLLGAC-------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 125 SLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L+ Q + A VARG+ +L +L +IL+ +N VAKI+ + L
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 188
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 29/174 (16%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHST----RNFMHHIELISKL-R 78
N+ +GEG+ GQ+ + R+K +K K +++ R+F +E++ KL
Sbjct: 15 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW--------------ISGHAWQ 124
H ++++ LG C ++L EY P+G L + I+
Sbjct: 75 HPNIINLLGAC-------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 127
Query: 125 SLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L+ Q + A VARG+ +L +L +IL+ +N VAKI+ + L
Sbjct: 128 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 178
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 19/152 (12%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKLRH 79
++FD +G+G G +Y R K FI A++ L +++K IE+ S LRH
Sbjct: 15 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHA----WQSLTWTQRISAA 135
+++ YF D RI+L+ E+ P G L + H +S T+ + ++ A
Sbjct: 75 PNILRMYN-----YFHDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 127
Query: 136 IGVARGIQFLHTGIVPGV----FSNNLKITDI 163
+ + +H I P + LKI D
Sbjct: 128 LHYCHERKVIHRDIKPENLLMGYKGELKIADF 159
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 19/152 (12%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKLRH 79
++FD +G+G G +Y R K FI A++ L +++K IE+ S LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHA----WQSLTWTQRISAA 135
+++ YF D RI+L+ E+ P G L + H +S T+ + ++ A
Sbjct: 74 PNILRMYN-----YFHDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 136 IGVARGIQFLHTGIVPGV----FSNNLKITDI 163
+ + +H I P + LKI D
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADF 158
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 72
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 73 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 123
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 158
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 50.8 bits (120), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +AI+ LK + S +F+ +++ KL+H LV E
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
I+++ EY+ G+L ++ ++L + A VA G+ ++
Sbjct: 76 --------EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM--- 124
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L+ KI+ + L L E+ E
Sbjct: 125 NYIHRDLRSANILVGNGLICKIADFGLARLIEDNE 159
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 31 FMGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSH-STRNFMHHIELISKLRHCHLVSA 85
+G G G++ GRL+ +AI+ LK + R+F+ ++ + H +++
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 86 LGHCFECYFDDSSVSR---IFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGI 142
G V+R ++ EY+ NG+L +++ H Q T Q + GV G+
Sbjct: 116 EG----------VVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGM 164
Query: 143 QFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVT 192
++L G +L ++L+D NLV K+S + L + E+ + T
Sbjct: 165 RYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 35/152 (23%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 42 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 96
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ HA + + + + + +G+++L T +L +IL++
Sbjct: 97 YLPYGSLRDYLQAHA-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 152
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 153 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 19/152 (12%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKLRH 79
++FD +G+G G +Y R K FI A++ L +++K IE+ S LRH
Sbjct: 14 DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHA----WQSLTWTQRISAA 135
+++ YF D RI+L+ E+ P G L + H +S T+ + ++ A
Sbjct: 74 PNILRMYN-----YFHDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 136 IGVARGIQFLHTGIVPGV----FSNNLKITDI 163
+ + +H I P + LKI D
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADF 158
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 34/149 (22%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKK--SHSTRNFMHHIELISKLRHCHLVSALGHC 89
+ E G++++GR + G I ++ LK++ + +R+F + H +++ LG C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 90 FECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGI 149
LI ++P G+L + + + +Q + A+ +ARG+ FLHT +
Sbjct: 77 -----QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130
Query: 150 VPGVFSNNLKITDILLDQNLVAKISSYNL 178
P + + L +++D+++ A+IS ++
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADV 159
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 86
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 87 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 137
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 172
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 78 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 82
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 83 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 133
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 168
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 83
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 84 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 134
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 169
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 78 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 83
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 84 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 134
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 169
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 87
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 88 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 138
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 173
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 77
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 78 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 79
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 80 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 130
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 165
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 78
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 79 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 129
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 164
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G T +A++ LK + S S F+ L+ +L+H LV
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 85
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
+ I++I EY+ NG+L ++ + LT + + A +A G+ F+
Sbjct: 86 ------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 136
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 171
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 92 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 145 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 178
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 74/164 (45%), Gaps = 27/164 (16%)
Query: 32 MGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSA 85
+GEG+ G+++ N +A++ LK ++ ++F EL++ L+H H+V
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-----------LTWTQRISA 134
G C E + ++FEY+ +G L ++ H + LT +Q +
Sbjct: 81 YGVCVEG-------DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 135 AIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
A +A G+ +L + +L + L+ +NL+ KI + +
Sbjct: 134 AQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGM 174
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 22/169 (13%)
Query: 32 MGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSAL 86
+G G G++ GRLK +AI+ LK+ + R +F+ ++ + H ++V
Sbjct: 51 IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 87 GHCFECYFDDSSVSR---IFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQ 143
G V+R + ++ E++ NG L +++ H Q T Q + G+A G++
Sbjct: 111 G----------VVTRGKPVMIVIEFMENGALDAFLRKHDGQ-FTVIQLVGMLRGIAAGMR 159
Query: 144 FLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVT 192
+L G +L +IL++ NLV K+S + L + E+ + + T
Sbjct: 160 YLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT 205
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 92 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 145 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 178
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 50.1 bits (118), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 83 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 135
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 136 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 169
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 50.1 bits (118), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 12/160 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G + G+ K +A++ +K + S S F + + KL H LV G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
Y I+++ EY+ NG L +++ H + L +Q + V G+ FL +
Sbjct: 75 EY-------PIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH--- 123
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHV 191
+L + L+D++L K+S + + + + V V
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 50.1 bits (118), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 33/140 (23%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 40 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 94
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T NL +IL++
Sbjct: 95 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRNLATRNILVEN 150
Query: 168 NLVAKISSYNL-PLLAENAE 186
KI + L +L ++ E
Sbjct: 151 ENRVKIGDFGLTKVLPQDKE 170
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 50.1 bits (118), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 66 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 151
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/136 (25%), Positives = 59/136 (43%), Gaps = 18/136 (13%)
Query: 47 NGTFIAIRCLKMKKSHSTRN-FMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
G +A++ LK R+ + IE++ L H H+V G C +D + L+
Sbjct: 36 TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCC-----EDQGEKSVQLV 90
Query: 106 FEYVPNGTLRSWISGHA---WQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITD 162
EYVP G+LR ++ H Q L + Q+I + ++H L +
Sbjct: 91 MEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRA---------LAARN 141
Query: 163 ILLDQNLVAKISSYNL 178
+LLD + + KI + L
Sbjct: 142 VLLDNDRLVKIGDFGL 157
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/136 (25%), Positives = 59/136 (43%), Gaps = 18/136 (13%)
Query: 47 NGTFIAIRCLKMKKSHSTRN-FMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLI 105
G +A++ LK R+ + IE++ L H H+V G C +D + L+
Sbjct: 37 TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCC-----EDQGEKSVQLV 91
Query: 106 FEYVPNGTLRSWISGHA---WQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITD 162
EYVP G+LR ++ H Q L + Q+I + ++H L +
Sbjct: 92 MEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRA---------LAARN 142
Query: 163 ILLDQNLVAKISSYNL 178
+LLD + + KI + L
Sbjct: 143 VLLDNDRLVKIGDFGL 158
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 71 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 39/167 (23%), Positives = 73/167 (43%), Gaps = 16/167 (9%)
Query: 31 FMGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSH-STRNFMHHIELISKLRHCHLVSA 85
+G G G++ GRL+ +AI+ LK + R+F+ ++ + H +++
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFL 145
G ++ EY+ NG+L +++ H Q T Q + GV G+++L
Sbjct: 116 EGVVTRGRL-------AMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL 167
Query: 146 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVT 192
G +L ++L+D NLV K+S + L + E+ T
Sbjct: 168 SD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT 211
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 66 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 151
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 71 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 67 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 66 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 67 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 69 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 154
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 69 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 155
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 69 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 155
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 68 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 154
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 66 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 69 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 154
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 66 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 71 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 65 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 117
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 118 NALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 150
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 66 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 151
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 70 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 122
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 123 NALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 155
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 67 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 69 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 154
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 66 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 118
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 119 NALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 151
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNG----TLRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P G L+ ++ T+ ++
Sbjct: 71 RHPNILRLYG-----YFHDAT--RVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 19/154 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNG----TLRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P G L+ ++ T+ ++
Sbjct: 71 RHPNILRLYG-----YFHDAT--RVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITDI 163
A+ + +H I P + LKI D
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/138 (26%), Positives = 65/138 (47%), Gaps = 15/138 (10%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 68 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 134 AAIGVARGIQFLHTGIVP 151
A+ + +H I P
Sbjct: 121 NALSYCHSKRVIHRDIKP 138
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/166 (22%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 32 MGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSAL 86
+G G G++ GRLK +AI+ LK+ + R +F+ ++ + H +++
Sbjct: 30 IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 87 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLH 146
G + + ++ EY+ NG+L +++ + Q T Q + G++ G+++L
Sbjct: 90 GVV-------TKSKPVMIVTEYMENGSLDTFLKKNDGQ-FTVIQLVGMLRGISAGMKYLS 141
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVT 192
G +L +IL++ NLV K+S + L + E+ + + T
Sbjct: 142 DM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 184
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/138 (26%), Positives = 65/138 (47%), Gaps = 15/138 (10%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 69 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 134 AAIGVARGIQFLHTGIVP 151
A+ + +H I P
Sbjct: 122 NALSYCHSKRVIHRDIKP 139
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKL 77
A +F+ +G+G G +Y R K FI A++ L +++K+ +E+ S L
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LRSWISGHAWQSLTWTQRIS 133
RH +++ G YF D++ R++LI EY P GT L+ ++ T+ ++
Sbjct: 63 RHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 115
Query: 134 AAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
A+ + +H I P + LKI D
Sbjct: 116 NALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 148
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 43 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 97
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 98 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 153
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 154 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 185
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 42 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 96
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 97 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 152
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 153 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/193 (22%), Positives = 86/193 (44%), Gaps = 25/193 (12%)
Query: 14 FSLEELEEATNNF----DTSAF-----MGEGSKGQMYRGRLK----NGTFIAIRCLKMKK 60
F+ E+ +A F D S +G G G++ GRLK +AI+ LK
Sbjct: 10 FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 61 SHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWIS 119
+ R +F+ ++ + H +++ G +C + +I EY+ NG+L +++
Sbjct: 70 TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKC-------KPVMIITEYMENGSLDAFLR 122
Query: 120 GHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 179
+ + T Q + G+ G+++L +L +IL++ NLV K+S + +
Sbjct: 123 KNDGR-FTVIQLVGMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMS 178
Query: 180 LLAENAEKVGHVT 192
+ E+ + + T
Sbjct: 179 RVLEDDPEAAYTT 191
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 44 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 98
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 99 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 154
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 155 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 186
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 46 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 100
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 101 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 156
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 157 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 188
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 45 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 99
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 100 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 155
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 156 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 187
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 39 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 93
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 94 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 149
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 150 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 181
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 70 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 124
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 125 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 180
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 181 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 212
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 38 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 92
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 93 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 148
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 149 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 180
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 37 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 91
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 92 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 147
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 148 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 179
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 39 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 93
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 94 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 149
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 150 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 181
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 4 GALGLPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMK 59
G LG + R ++LE +FD +G+G G +Y R + FI A++ L +++
Sbjct: 1 GPLG--SKRQWTLE-------DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLE 51
Query: 60 KSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWIS 119
K+ +E+ S LRH +++ G YF D++ R++LI EY P GT+ +
Sbjct: 52 KAGVEHQLRREVEIQSHLRHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYREL- 103
Query: 120 GHAWQSLTW--TQRISAAIG-VARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
Q L+ QR + I +A + + H+ V ++K ++LL N KI+ +
Sbjct: 104 ----QKLSRFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADF 156
Query: 177 NLPLLAENAEKV 188
+ A ++ +
Sbjct: 157 GWSVHAPSSRRT 168
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 57 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 111
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 112 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 167
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 168 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 32/140 (22%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 57 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 111
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 112 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 167
Query: 168 NLVAKISSYNL-PLLAENAE 186
KI + L +L ++ E
Sbjct: 168 ENRVKIGDFGLTKVLPQDKE 187
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 32/140 (22%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 39 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 93
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
Y+P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 94 YLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 149
Query: 168 NLVAKISSYNL-PLLAENAE 186
KI + L +L ++ E
Sbjct: 150 ENRVKIGDFGLTKVLPQDKE 169
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 28/171 (16%)
Query: 4 GALGLPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMK 59
G LG + R ++LE +FD +G+G G +Y R + FI A++ L +++
Sbjct: 1 GPLG--SKRQWTLE-------DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLE 51
Query: 60 KSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT----LR 115
K+ +E+ S LRH +++ G YF D++ R++LI EY P GT L+
Sbjct: 52 KAGVEHQLRREVEIQSHLRHPNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQ 104
Query: 116 SWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVF----SNNLKITD 162
++ T+ ++ A+ + +H I P + LKI D
Sbjct: 105 KLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIAD 155
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 47.8 bits (112), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 34/155 (21%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G N T +A++ LK + S + F+ L+ L+H LV
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLV-------R 72
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
Y + I++I EY+ G+L ++ + + I + +A G+ ++
Sbjct: 73 LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--- 129
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ ++L+ ++L+ KI+ + L + E+ E
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 164
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 47.4 bits (111), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 45/185 (24%), Positives = 83/185 (44%), Gaps = 25/185 (13%)
Query: 14 FSLEELEEATNNF----DTSAF-----MGEGSKGQMYRGRLK----NGTFIAIRCLKMKK 60
F+ E+ EA F D S +G G G++ G LK F+AI+ LK
Sbjct: 14 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 61 SHSTR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWIS 119
+ R +F+ ++ + H +++ G + + + +I E++ NG+L S++
Sbjct: 74 TEKQRRDFLSEASIMGQFDHPNVIHLEGVV-------TKSTPVMIITEFMENGSLDSFLR 126
Query: 120 GHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 179
+ Q T Q + G+A G+++L +L +IL++ NLV K+S + L
Sbjct: 127 QNDGQ-FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLS 182
Query: 180 LLAEN 184
E+
Sbjct: 183 RFLED 187
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 47.4 bits (111), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 37/172 (21%), Positives = 70/172 (40%), Gaps = 41/172 (23%)
Query: 32 MGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSA 85
+GEG+ G+++ N +A++ LK + ++F EL++ L+H H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHA-------------------WQSL 126
G C E + ++FEY+ +G L ++ H Q L
Sbjct: 109 FGVCTEG-------RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 127 TWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+++A + G+ F+H +L + L+ Q LV KI + +
Sbjct: 162 AVASQVAAGMVYLAGLHFVH---------RDLATRNCLVGQGLVVKIGDFGM 204
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 47.0 bits (110), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 34/149 (22%), Positives = 69/149 (46%), Gaps = 9/149 (6%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKK--SHSTRNFMHHIELISKLRHCHLVSALGHC 89
+ E G++++GR + G I ++ LK++ + +R+F + H +++ LG C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 90 FECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGI 149
LI + P G+L + + + +Q + A+ ARG FLHT +
Sbjct: 77 -----QSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT-L 130
Query: 150 VPGVFSNNLKITDILLDQNLVAKISSYNL 178
P + + L + +D++ A+IS ++
Sbjct: 131 EPLIPRHALNSRSVXIDEDXTARISXADV 159
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 47.0 bits (110), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 33/152 (21%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 48 GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFE 107
G +A++ L+ R+F IE++ L+H ++V G C+ + + LI E
Sbjct: 42 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY-----SAGRRNLKLIME 96
Query: 108 YVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQ 167
++P G+LR ++ H + + + + + +G+++L T +L +IL++
Sbjct: 97 FLPYGSLREYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVEN 152
Query: 168 NLVAKISSYNL-PLLAENAEKVGHVTPYSGSI 198
KI + L +L ++ E P I
Sbjct: 153 ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 47.0 bits (110), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 33/155 (21%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G+++ G N T +A++ LK + S + F+ L+ L+H LV
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLV-------R 71
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVP 151
Y + I++I E++ G+L ++ + + I + +A G+ ++
Sbjct: 72 LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--- 128
Query: 152 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+L+ ++L+ ++L+ KI+ + L + E+ E
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 163
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 47.0 bits (110), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 37/172 (21%), Positives = 70/172 (40%), Gaps = 41/172 (23%)
Query: 32 MGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSA 85
+GEG+ G+++ N +A++ LK + ++F EL++ L+H H+V
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHA-------------------WQSL 126
G C E + ++FEY+ +G L ++ H Q L
Sbjct: 80 FGVCTEG-------RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 132
Query: 127 TWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+++A + G+ F+H +L + L+ Q LV KI + +
Sbjct: 133 AVASQVAAGMVYLAGLHFVH---------RDLATRNCLVGQGLVVKIGDFGM 175
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 46.6 bits (109), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 37/172 (21%), Positives = 70/172 (40%), Gaps = 41/172 (23%)
Query: 32 MGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSA 85
+GEG+ G+++ N +A++ LK + ++F EL++ L+H H+V
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHA-------------------WQSL 126
G C E + ++FEY+ +G L ++ H Q L
Sbjct: 86 FGVCTEG-------RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 138
Query: 127 TWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+++A + G+ F+H +L + L+ Q LV KI + +
Sbjct: 139 AVASQVAAGMVYLAGLHFVH---------RDLATRNCLVGQGLVVKIGDFGM 181
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 22/193 (11%)
Query: 17 EELEEATNNFDTS-----AFMGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSH-STRN 66
E + E D S +G G G++ RGRLK + +AI+ LK + R
Sbjct: 4 EAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRRE 63
Query: 67 FMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSL 126
F+ ++ + H +++ G ++ + ++ E++ NG L S++ + Q
Sbjct: 64 FLSEASIMGQFEHPNIIRLEGVV-------TNSMPVMILTEFMENGALDSFLRLNDGQ-F 115
Query: 127 TWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP-LLAENA 185
T Q + G+A G+++L +L +IL++ NLV K+S + L L EN+
Sbjct: 116 TVIQLVGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS 172
Query: 186 EKVGHVTPYSGSI 198
+ G I
Sbjct: 173 SDPTETSSLGGKI 185
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 42/173 (24%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 32 MGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSH-STRNFMHHIELISKLRHCHLVSAL 86
+G G G++ RGRLK + +AI+ LK + R F+ ++ + H +++
Sbjct: 22 IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 87 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLH 146
G ++ + ++ E++ NG L S++ + Q T Q + G+A G+++L
Sbjct: 82 GVV-------TNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGIASGMRYLA 133
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLP-LLAENAEKVGHVTPYSGSI 198
+L +IL++ NLV K+S + L L EN+ + + G I
Sbjct: 134 EM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/166 (22%), Positives = 77/166 (46%), Gaps = 16/166 (9%)
Query: 32 MGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSAL 86
+G G G++ GRLK +AI+ LK + R +F+ ++ + H +++
Sbjct: 16 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 87 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLH 146
G +C + +I EY+ NG+L +++ + + T Q + G+ G+++L
Sbjct: 76 GVVTKC-------KPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSGMKYLS 127
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVT 192
+L +IL++ NLV K+S + + + E+ + + T
Sbjct: 128 DM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT 170
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/166 (22%), Positives = 77/166 (46%), Gaps = 16/166 (9%)
Query: 32 MGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSAL 86
+G G G++ GRLK +AI+ LK + R +F+ ++ + H +++
Sbjct: 22 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 87 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLH 146
G +C + +I EY+ NG+L +++ + + T Q + G+ G+++L
Sbjct: 82 GVVTKC-------KPVMIITEYMENGSLDAFLRKNDGR-FTVIQLVGMLRGIGSGMKYLS 133
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVT 192
+L +IL++ NLV K+S + + + E+ + + T
Sbjct: 134 DM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT 176
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G ++ G N +AI+ +K + S S +F+ E++ KL H LV G C E
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQR--------ISAAIGVARGIQ 143
+ I L+FE++ +G L ++ TQR + + V G+
Sbjct: 94 -------QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMA 137
Query: 144 FLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L V +L + L+ +N V K+S + +
Sbjct: 138 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 169
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 35/151 (23%), Positives = 70/151 (46%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYR-GRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G+G GQ + + G + ++ L + R F+ ++++ L H +++ +G +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ R+ I EY+ GTLR I Q W+QR+S A +A G+ +LH+
Sbjct: 78 K-------DKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+ +L + L+ +N ++ + L L
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARL 157
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 44.3 bits (103), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 24/170 (14%)
Query: 18 ELEEATNNFDTSAFMGEGSKGQMYRGRLKN-GTFIAIRCLKM-----KKSHSTRNFMHHI 71
+++ ++ F+GEG +Y+ R KN +AI+ +K+ K R + I
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 72 ELISKLRHCH---LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTW 128
+L+ +L H + L+ A GH S I L+F+++ L I ++ LT
Sbjct: 64 KLLQELSHPNIIGLLDAFGH----------KSNISLVFDFM-ETDLEVIIKDNSL-VLTP 111
Query: 129 TQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ + + +G+++LH + +LK ++LLD+N V K++ + L
Sbjct: 112 SHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G ++ G N +AI+ ++ + + S +F+ E++ KL H LV G C E
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQR--------ISAAIGVARGIQ 143
+ I L+FE++ +G L ++ TQR + + V G+
Sbjct: 74 -------QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMA 117
Query: 144 FLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L V +L + L+ +N V K+S + +
Sbjct: 118 YLEEA---SVIHRDLAARNCLVGENQVIKVSDFGM 149
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 43.9 bits (102), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 38/167 (22%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 32 MGEGSKGQMYRGRLKNGT-----FIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSA 85
+G G G++Y+G LK + +AI+ LK + R +F+ ++ + H +++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFL 145
G S + +I EY+ NG L ++ + + Q + G+A G+++L
Sbjct: 112 EGVI-------SKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYL 163
Query: 146 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVT 192
+L +IL++ NLV K+S + L + E+ + + T
Sbjct: 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 43.9 bits (102), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G ++ G N +AI+ ++ + + S +F+ E++ KL H LV G C E
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQR--------ISAAIGVARGIQ 143
+ I L+FE++ +G L ++ TQR + + V G+
Sbjct: 74 -------QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMA 117
Query: 144 FLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L V +L + L+ +N V K+S + +
Sbjct: 118 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 149
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 43.9 bits (102), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G ++ G N +AI+ ++ + + S +F+ E++ KL H LV G C E
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQR--------ISAAIGVARGIQ 143
+ I L+FE++ +G L ++ TQR + + V G+
Sbjct: 77 -------QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMA 120
Query: 144 FLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L V +L + L+ +N V K+S + +
Sbjct: 121 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 152
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 43.9 bits (102), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 36/167 (21%), Positives = 71/167 (42%), Gaps = 30/167 (17%)
Query: 32 MGEGSKGQMYRGRL------KNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSA 85
+GEG+ G+++ K+ +A++ LK + ++F EL++ L+H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGH--------------AWQSLTWTQR 131
G C + ++FEY+ +G L ++ H A L +Q
Sbjct: 83 YGVC-------GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 132 ISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ A +A G+ +L + +L + L+ NL+ KI + +
Sbjct: 136 LHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGM 179
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 43.9 bits (102), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G ++ G N +AI+ ++ + + S +F+ E++ KL H LV G C E
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQR--------ISAAIGVARGIQ 143
+ I L+FE++ +G L ++ TQR + + V G+
Sbjct: 72 -------QAPICLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMA 115
Query: 144 FLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L V +L + L+ +N V K+S + +
Sbjct: 116 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 147
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 43.5 bits (101), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 34/165 (20%), Positives = 74/165 (44%), Gaps = 19/165 (11%)
Query: 25 NFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLV 83
+F +G G GQ+++ + + +G I+ +K + R ++ ++KL H ++V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 84 SALGHCFECY-FDDSSVSR---------IFLIFEYVPNGTLRSWISGHAWQSLTWTQRIS 133
G C++ + +D + S+ +F+ E+ GTL WI + L +
Sbjct: 68 HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 134 AAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ +G+ ++H+ + + +LK ++I L KI + L
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGL 168
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 43.5 bits (101), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 34/177 (19%), Positives = 76/177 (42%), Gaps = 12/177 (6%)
Query: 15 SLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIEL 73
S+++ E + +G G G++Y G K + +A++ LK + + F+ +
Sbjct: 23 SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 81
Query: 74 ISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRIS 133
+ +++H +LV LG C + +++ EY+P G L ++ + +T +
Sbjct: 82 MKEIKHPNLVQLLGVC-------TLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLY 134
Query: 134 AAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGH 190
A ++ +++L +L + L+ +N V K++ + L L H
Sbjct: 135 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAH 188
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 43.1 bits (100), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 38/158 (24%), Positives = 73/158 (46%), Gaps = 16/158 (10%)
Query: 32 MGEGSKGQMYRGRLK----NGTFIAIRCLKMKKSHSTR-NFMHHIELISKLRHCHLVSAL 86
+G G G++ G LK F+AI+ LK + R +F+ ++ + H +++
Sbjct: 15 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 87 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLH 146
G + + + +I E++ NG+L S++ + Q T Q + G+A G+++L
Sbjct: 75 GVV-------TKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYLA 126
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 184
L +IL++ NLV K+S + L E+
Sbjct: 127 DM---NYVHRALAARNILVNSNLVCKVSDFGLSRFLED 161
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 32 MGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHSTR---NFMHHIELISKLRHCHLVSALG 87
+G G+ G++ G+ + G +A++ L +K S I+ + RH H++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII---- 79
Query: 88 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHT 147
+ Y S+ S IF++ EYV G L +I + ++R+ I G+ + H
Sbjct: 80 ---KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI--LSGVDYCHR 134
Query: 148 GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+ V +LK ++LLD ++ AKI+ + L + + E
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 21/162 (12%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKN-GTFIAIRCLKMK---KSHSTRNFMHHIELISKLRH 79
+NF+ +G+GS G++ R+K G A++ LK + M ++S R+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQ---RISAAI 136
++ L CF+ + R+F + E+V G L H +S + + R AA
Sbjct: 83 HPFLTQLFCCFQ------TPDRLFFVMEFVNGGDLMF----HIQKSRRFDEARARFYAA- 131
Query: 137 GVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ + FLH G+ +LK+ ++LLD K++ + +
Sbjct: 132 EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 170
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 25 NFDTSAFMGEGSKGQMYRGRLKN-GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLV 83
+F+ +G+GS G+++ K F AI+ LK + L+ C +V
Sbjct: 19 DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-----------KDVVLMDDDVECTMV 67
Query: 84 SA-----------LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRI 132
L H F C F + +F + EY+ G L I + ++
Sbjct: 68 EKRVLSLAWEHPFLTHMF-CTF--QTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRAT 122
Query: 133 SAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
A + G+QFLH+ G+ +LK+ +ILLD++ KI+ + +
Sbjct: 123 FYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM 165
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/136 (25%), Positives = 60/136 (44%), Gaps = 15/136 (11%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCL---KMKKSHSTRNFMHHIELISKLRH 79
++F+ +G+G G +Y R K FI A++ L +++K IE+ + L H
Sbjct: 23 DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISG----HAWQSLTWTQRISAA 135
+++ YF D RI+LI EY P G L + ++ T + ++ A
Sbjct: 83 PNILRLYN-----YFYDRR--RIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADA 135
Query: 136 IGVARGIQFLHTGIVP 151
+ G + +H I P
Sbjct: 136 LMYCHGKKVIHRDIKP 151
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 35/160 (21%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 31 FMGEGSKGQMYRGRLKNGTFIAIRCLKMKK----SHSTRNFMHHIELISKLRHCHLVSAL 86
+G G G++YR G +A++ + S + N +L + L+H ++++
Sbjct: 14 IIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 87 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLH 146
G C + + L+ E+ G L +SG + + ++ A+ +ARG+ +LH
Sbjct: 73 GVCLK-------EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLH 122
Query: 147 TGIVPGVFSNNLKITDILLDQ--------NLVAKISSYNL 178
+ + +LK ++IL+ Q N + KI+ + L
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 22/165 (13%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G + G+ + +AI+ +K + S S F+ +++ L H LV G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-- 88
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISG--HAWQS---LTWTQRISAAIGVARGIQFLH 146
+ IF+I EY+ NG L +++ H +Q+ L + + A+ QFLH
Sbjct: 89 -----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHV 191
+L + L++ V K+S + L + E+ V
Sbjct: 144 ---------RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV 179
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 40.8 bits (94), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 22/152 (14%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G + G+ + +AI+ +K + S S F+ +++ L H LV G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-- 88
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISG--HAWQS---LTWTQRISAAIGVARGIQFLH 146
+ IF+I EY+ NG L +++ H +Q+ L + + A+ QFLH
Sbjct: 89 -----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L + L++ V K+S + L
Sbjct: 144 ---------RDLAARNCLVNDQGVVKVSDFGL 166
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 40.8 bits (94), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 40/174 (22%), Positives = 72/174 (41%), Gaps = 23/174 (13%)
Query: 17 EELEEATNNFDTSAF--------MGEGSKGQ-MYRGRLKNGTFIAIRCLKMK---KSHST 64
E+ ++ +NN D +G+GS G+ M R AI+ LK +
Sbjct: 4 EDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDV 63
Query: 65 RNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQ 124
M +++ L ++ L CF+ +V R++ + EYV G L I
Sbjct: 64 ECTMVEKRVLALLDKPPFLTQLHSCFQ------TVDRLYFVMEYVNGGDLMYHIQQVG-- 115
Query: 125 SLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
Q + A ++ G+ FLH G+ +LK+ +++LD KI+ + +
Sbjct: 116 KFKEPQAVFYAAEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGM 166
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 40.8 bits (94), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 36/155 (23%), Positives = 67/155 (43%), Gaps = 28/155 (18%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G ++ G N +AI+ ++ + + S +F+ E++ KL H LV G C E
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQR--------ISAAIGVARGIQ 143
+ I L+ E++ +G L ++ TQR + + V G+
Sbjct: 75 -------QAPICLVTEFMEHGCLSDYLR---------TQRGLFAAETLLGMCLDVCEGMA 118
Query: 144 FLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L V +L + L+ +N V K+S + +
Sbjct: 119 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 150
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 40.8 bits (94), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 22/152 (14%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G + G+ + +AI+ +K + S S F+ +++ L H LV G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-- 68
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISG--HAWQS---LTWTQRISAAIGVARGIQFLH 146
+ IF+I EY+ NG L +++ H +Q+ L + + A+ QFLH
Sbjct: 69 -----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L + L++ V K+S + L
Sbjct: 124 ---------RDLAARNCLVNDQGVVKVSDFGL 146
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 40.8 bits (94), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 33/177 (18%), Positives = 75/177 (42%), Gaps = 12/177 (6%)
Query: 15 SLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIEL 73
SL++ E + +G G G++Y G K + +A++ LK + + F+ +
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 60
Query: 74 ISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRIS 133
+ +++H +LV LG C + ++I E++ G L ++ Q ++ +
Sbjct: 61 MKEIKHPNLVQLLGVC-------TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY 113
Query: 134 AAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGH 190
A ++ +++L +L + L+ +N + K++ + L L H
Sbjct: 114 MATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH 167
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 40.8 bits (94), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 22/152 (14%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G + G+ + +AI+ +K + S S F+ +++ L H LV G C
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-- 79
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISG--HAWQS---LTWTQRISAAIGVARGIQFLH 146
+ IF+I EY+ NG L +++ H +Q+ L + + A+ QFLH
Sbjct: 80 -----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 134
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L + L++ V K+S + L
Sbjct: 135 ---------RDLAARNCLVNDQGVVKVSDFGL 157
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 40.4 bits (93), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 66/145 (45%), Gaps = 22/145 (15%)
Query: 32 MGEGSKGQMYRGR-LKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G+G+ G +Y GR L N IAI+ + + S ++ I L L+H ++V LG
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS-- 73
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLT--------WTQRISAAIGVARGI 142
F ++ +IF+ E VP G+L + + W L +T++I +
Sbjct: 74 ---FSENGFIKIFM--EQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 143 QFLHTGI-----VPGVFSNNLKITD 162
Q +H I + +S LKI+D
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISD 152
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 40.4 bits (93), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 66/145 (45%), Gaps = 22/145 (15%)
Query: 32 MGEGSKGQMYRGR-LKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G+G+ G +Y GR L N IAI+ + + S ++ I L L+H ++V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS-- 87
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLT--------WTQRISAAIGVARGI 142
F ++ +IF+ E VP G+L + + W L +T++I +
Sbjct: 88 ---FSENGFIKIFM--EQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 143 QFLHTGI-----VPGVFSNNLKITD 162
Q +H I + +S LKI+D
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISD 166
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 27/170 (15%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLV 83
+N +G G G +Y+G L +A++ + +NF++ ++ + V
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSLDERP-VAVKVFSFA---NRQNFINE-------KNIYRV 61
Query: 84 SALGHCFECYF--DDSSVS-----RIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAI 136
+ H F D V+ L+ EY PNG+L ++S H + W A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAH 118
Query: 137 GVARGIQFLHTGIV------PGVFSNNLKITDILLDQNLVAKISSYNLPL 180
V RG+ +LHT + P + +L ++L+ + IS + L +
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 22/152 (14%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G + G+ + +AI+ +K + S S F+ +++ L H LV G C
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-- 72
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISG--HAWQS---LTWTQRISAAIGVARGIQFLH 146
+ IF+I EY+ NG L +++ H +Q+ L + + A+ QFLH
Sbjct: 73 -----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 127
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L + L++ V K+S + L
Sbjct: 128 ---------RDLAARNCLVNDQGVVKVSDFGL 150
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 22/152 (14%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G + G+ + +AI+ +K + S S F+ +++ L H LV G C
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-- 73
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISG--HAWQS---LTWTQRISAAIGVARGIQFLH 146
+ IF+I EY+ NG L +++ H +Q+ L + + A+ QFLH
Sbjct: 74 -----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L + L++ V K+S + L
Sbjct: 129 ---------RDLAARNCLVNDQGVVKVSDFGL 151
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 22/152 (14%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G G G + G+ + +AI+ +K + S S F+ +++ L H LV G C
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-- 73
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISG--HAWQS---LTWTQRISAAIGVARGIQFLH 146
+ IF+I EY+ NG L +++ H +Q+ L + + A+ QFLH
Sbjct: 74 -----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 147 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+L + L++ V K+S + L
Sbjct: 129 ---------RDLAARNCLVNDQGVVKVSDFGL 151
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 40.4 bits (93), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 31/166 (18%)
Query: 25 NFDTSAFMGEGSKGQMYRGRLKN-GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLV 83
+F +G+GS G+++ K F AI+ LK + L+ C +V
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-----------KDVVLMDDDVECTMV 66
Query: 84 SA-----------LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRI 132
L H F C F + +F + EY+ G L I + ++
Sbjct: 67 EKRVLSLAWEHPFLTHMF-CTF--QTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRAT 121
Query: 133 SAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
A + G+QFLH+ G+ +LK+ +ILLD++ KI+ + +
Sbjct: 122 FYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM 164
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 40.0 bits (92), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 40/188 (21%), Positives = 79/188 (42%), Gaps = 39/188 (20%)
Query: 20 EEATNNFDTSAFMGEGSKGQMYRGR------LKNGTFIAIRCLKMKKSHSTR-NFMHHIE 72
E NN + +GEG+ G++++ R + T +A++ LK + S + +F
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 73 LISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTL------------------ 114
L+++ + ++V LG C + + L+FEY+ G L
Sbjct: 103 LMAEFDNPNIVKLLGVC-------AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155
Query: 115 ----RSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLV 170
R+ +S L+ +++ A VA G+ +L +L + L+ +N+V
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMV 212
Query: 171 AKISSYNL 178
KI+ + L
Sbjct: 213 VKIADFGL 220
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 38/159 (23%), Positives = 71/159 (44%), Gaps = 16/159 (10%)
Query: 32 MGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHSTR---NFMHHIELISKLRHCHLVSALG 87
+G G+ G++ G + G +A++ L +K S I+ + RH H++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII---- 74
Query: 88 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHT 147
+ Y S+ + F++ EYV G L +I H +R+ I A + + H
Sbjct: 75 ---KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCHR 129
Query: 148 GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+ V +LK ++LLD ++ AKI+ + L + + E
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 38/159 (23%), Positives = 71/159 (44%), Gaps = 16/159 (10%)
Query: 32 MGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHSTR---NFMHHIELISKLRHCHLVSALG 87
+G G+ G++ G + G +A++ L +K S I+ + RH H++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII---- 74
Query: 88 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHT 147
+ Y S+ + F++ EYV G L +I H +R+ I A + + H
Sbjct: 75 ---KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCHR 129
Query: 148 GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 186
+ V +LK ++LLD ++ AKI+ + L + + E
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 35/163 (21%), Positives = 77/163 (47%), Gaps = 17/163 (10%)
Query: 35 GSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYF 94
G G +++ +L N ++A++ ++ S +N + + + ++H +++ +G
Sbjct: 35 GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIG----AEK 88
Query: 95 DDSSVS-RIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV--- 150
+SV ++LI + G+L ++ + ++W + A +ARG+ +LH I
Sbjct: 89 RGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 151 ----PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVG 189
P + ++K ++LL NL A I+ + L L E + G
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 33/176 (18%), Positives = 75/176 (42%), Gaps = 17/176 (9%)
Query: 7 GLPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTR 65
G P Y + +E + +G G G++Y G K + +A++ LK + +
Sbjct: 1 GSPNYDKWEMER-----TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 54
Query: 66 NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS 125
F+ ++ +++H +LV LG C + ++I E++ G L ++ Q
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVC-------TREPPFYIIIEFMTYGNLLDYLRECNRQE 107
Query: 126 LTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
++ + A ++ +++L +L + L+ +N + K++ + L L
Sbjct: 108 VSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 33/176 (18%), Positives = 75/176 (42%), Gaps = 17/176 (9%)
Query: 7 GLPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTR 65
G P Y + +E + +G G G++Y G K + +A++ LK + +
Sbjct: 1 GSPNYDKWEMER-----TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 54
Query: 66 NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS 125
F+ ++ +++H +LV LG C + ++I E++ G L ++ Q
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVC-------TREPPFYIIIEFMTYGNLLDYLRECNRQE 107
Query: 126 LTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
++ + A ++ +++L +L + L+ +N + K++ + L L
Sbjct: 108 VSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/169 (18%), Positives = 74/169 (43%), Gaps = 12/169 (7%)
Query: 14 FSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIE 72
SL++ E + +G G G++Y G K + +A++ LK + + F+
Sbjct: 1 MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAA 59
Query: 73 LISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRI 132
++ +++H +LV LG C + ++I E++ G L ++ Q ++ +
Sbjct: 60 VMKEIKHPNLVQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 112
Query: 133 SAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
A ++ +++L +L + L+ +N + K++ + L L
Sbjct: 113 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 158
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/168 (21%), Positives = 67/168 (39%), Gaps = 9/168 (5%)
Query: 14 FSLEELEEATNNFDTSAFMGEGSKGQMYRGR-LKNGTFIAIRCLKMKKSHSTRNFMHHIE 72
L L + F+ +G G+ GQ+Y+GR +K G AI+ + + I
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEIN 72
Query: 73 LISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLT--WTQ 130
++ K H ++ F +++L+ E+ G++ I +L W
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 131 RISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
I I RG+ LH V ++K ++LL +N K+ + +
Sbjct: 133 YICREI--LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 175
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE+V + L+ ++ A + S +
Sbjct: 64 HPNIVKLLDVI-------HTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 152
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/153 (21%), Positives = 70/153 (45%), Gaps = 15/153 (9%)
Query: 32 MGEGSKGQMYRGRLK-----NGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRHCHLVSA 85
+GEG G++ R G +A++ LK + + + IE++ L H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFL 145
G C E + I LI E++P+G+L+ ++ + + Q++ A+ + +G+ +L
Sbjct: 89 KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYL 142
Query: 146 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ +L ++L++ KI + L
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/151 (19%), Positives = 68/151 (45%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 285
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q ++ + A ++ +++L
Sbjct: 286 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 337
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
NL + L+ +N + K++ + L L
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRL 367
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/158 (20%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE+V + L++++ A + S + +
Sbjct: 62 NIVKLLDVI-------HTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/178 (18%), Positives = 75/178 (42%), Gaps = 12/178 (6%)
Query: 14 FSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIE 72
SL++ E + +G G G++Y G K + +A++ LK + + F+
Sbjct: 1 MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAA 59
Query: 73 LISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRI 132
++ +++H +LV LG C + ++I E++ G L ++ Q ++ +
Sbjct: 60 VMKEIKHPNLVQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 112
Query: 133 SAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGH 190
A ++ +++L +L + L+ +N + K++ + L L H
Sbjct: 113 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH 167
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/161 (20%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 21 EATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKL 77
E NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 7 EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIG 137
H ++V L + ++++L+FE++ + L+ ++ A + S
Sbjct: 67 NHPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 138 VARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ +G+ F H+ V +LK ++L++ K++ + L
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 156
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/153 (21%), Positives = 70/153 (45%), Gaps = 15/153 (9%)
Query: 32 MGEGSKGQMYRGRLK-----NGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRHCHLVSA 85
+GEG G++ R G +A++ LK + + + IE++ L H ++V
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFL 145
G C E + I LI E++P+G+L+ ++ + + Q++ A+ + +G+ +L
Sbjct: 77 KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYL 130
Query: 146 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ +L ++L++ KI + L
Sbjct: 131 GSR---QYVHRDLAARNVLVESEHQVKIGDFGL 160
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/161 (20%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 21 EATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKL 77
E NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 7 EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 78 RHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIG 137
H ++V L + ++++L+FE++ + L+ ++ A + S
Sbjct: 67 NHPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 138 VARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ +G+ F H+ V +LK ++L++ K++ + L
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 156
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/160 (18%), Positives = 68/160 (42%), Gaps = 12/160 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 79
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 80 ------TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 131
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGH 190
+L + L+ +N + K++ + L L H
Sbjct: 132 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH 170
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/176 (18%), Positives = 75/176 (42%), Gaps = 17/176 (9%)
Query: 7 GLPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTR 65
G P Y + +E + +G G G++Y G K + +A++ LK + +
Sbjct: 1 GSPNYDKWEMER-----TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 54
Query: 66 NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS 125
F+ ++ +++H +LV LG C + ++I E++ G L ++ Q
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 126 LTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
++ + A ++ +++L +L + L+ +N + K++ + L L
Sbjct: 108 VSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 83
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 84 ------TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 135
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 136 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 165
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 38.5 bits (88), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/176 (18%), Positives = 75/176 (42%), Gaps = 17/176 (9%)
Query: 7 GLPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTR 65
G P Y + +E + +G G G++Y G K + +A++ LK + +
Sbjct: 1 GSPNYDKWEMER-----TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 54
Query: 66 NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS 125
F+ ++ +++H +LV LG C + ++I E++ G L ++ Q
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 126 LTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
++ + A ++ +++L +L + L+ +N + K++ + L L
Sbjct: 108 VSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/178 (19%), Positives = 70/178 (39%), Gaps = 32/178 (17%)
Query: 25 NFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLV 83
+F +G G GQ+++ + + +G IR +K + R ++ ++KL H ++V
Sbjct: 13 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIV 68
Query: 84 SALGHCFECYFDDSSVSR-----------------------IFLIFEYVPNGTLRSWISG 120
G C++ + D S +F+ E+ GTL WI
Sbjct: 69 HYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 121 HAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ L + + +G+ ++H+ + +LK ++I L KI + L
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGL 182
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L++++ A + S +
Sbjct: 64 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQL 115
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 152
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 225 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 282
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 283 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 334
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
NL + L+ +N + K++ + L L
Sbjct: 335 -NFIHRNLAARNCLVGENHLVKVADFGLSRL 364
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 324
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 325 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 376
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
NL + L+ +N + K++ + L L
Sbjct: 377 -NFIHRNLAARNCLVGENHLVKVADFGLSRL 406
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 68/151 (45%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 83
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q ++ + A ++ +++L
Sbjct: 84 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 135
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 136 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 165
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 39/203 (19%)
Query: 5 ALGLPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRG---RLKNG---TFIAIRCLKM 58
+L + A++ + E N +GEG G++ + LK T +A++ LK
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 59 KKSHST-RNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW 117
S S R+ + ++ ++ H H++ G C S + LI EY G+LR +
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-------SQDGPLLLIVEYAKYGSLRGF 116
Query: 118 IS-----GHAW-----------------QSLTWTQRISAAIGVARGIQFLHTGIVPGVFS 155
+ G + ++LT IS A +++G+Q+L +
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---SLVH 173
Query: 156 NNLKITDILLDQNLVAKISSYNL 178
+L +IL+ + KIS + L
Sbjct: 174 RDLAARNILVAEGRKMKISDFGL 196
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 38.1 bits (87), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 61 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQL 112
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGL 149
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 38.1 bits (87), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 39/203 (19%)
Query: 5 ALGLPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRG---RLKNG---TFIAIRCLKM 58
+L + A++ + E N +GEG G++ + LK T +A++ LK
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 59 KKSHST-RNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW 117
S S R+ + ++ ++ H H++ G C S + LI EY G+LR +
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-------SQDGPLLLIVEYAKYGSLRGF 116
Query: 118 IS-----GHAW-----------------QSLTWTQRISAAIGVARGIQFLHTGIVPGVFS 155
+ G + ++LT IS A +++G+Q+L +
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173
Query: 156 NNLKITDILLDQNLVAKISSYNL 178
+L +IL+ + KIS + L
Sbjct: 174 RDLAARNILVAEGRKMKISDFGL 196
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 67 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 153
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 30/160 (18%), Positives = 68/160 (42%), Gaps = 12/160 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 83
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 84 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 135
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGH 190
+L + L+ +N + K++ + L L H
Sbjct: 136 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH 174
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 64 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 152
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 63 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 151
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 39/203 (19%)
Query: 5 ALGLPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRG---RLKNG---TFIAIRCLKM 58
+L + A++ + E N +GEG G++ + LK T +A++ LK
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 59 KKSHST-RNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW 117
S S R+ + ++ ++ H H++ G C S + LI EY G+LR +
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-------SQDGPLLLIVEYAKYGSLRGF 116
Query: 118 IS-----GHAW-----------------QSLTWTQRISAAIGVARGIQFLHTGIVPGVFS 155
+ G + ++LT IS A +++G+Q+L +
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173
Query: 156 NNLKITDILLDQNLVAKISSYNL 178
+L +IL+ + KIS + L
Sbjct: 174 RDLAARNILVAEGRKMKISDFGL 196
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 65 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 117 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 153
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 63 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGL 151
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 33/176 (18%), Positives = 74/176 (42%), Gaps = 17/176 (9%)
Query: 7 GLPAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTR 65
G P Y + +E + +G G G++Y G K + +A++ LK + +
Sbjct: 14 GSPNYDKWEMER-----TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 67
Query: 66 NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS 125
F+ ++ +++H +LV LG C + ++I E++ G L ++ Q
Sbjct: 68 EFLKEAAVMKEIKHPNLVQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQE 120
Query: 126 LTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+ + A ++ +++L +L + L+ +N + K++ + L L
Sbjct: 121 VNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 173
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 63 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 151
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 64 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 152
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 61 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 79
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 80 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 131
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 132 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 161
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 63 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 115 GLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 62 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 150
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 62 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGL 150
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 61 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 62 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 150
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 62 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 64 HPNIVKLLDVI-------HTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGL 152
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 83
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 84 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 135
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 136 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 165
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 64 HPNIVKLLDVI-------HTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL 115
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 116 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 152
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 61 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 63 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 62 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 82
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 83 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 134
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 135 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 164
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 62 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 80
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 81 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 132
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 133 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 162
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 63 HPNIVKLLDVI-------HTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL 114
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 115 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 151
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 63 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 63 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 83
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 84 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 135
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 136 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 165
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 78
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 79 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 130
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 160
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 37.7 bits (86), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 80
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 81 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 132
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 133 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 162
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 62 HPNIVKLLDVI-------HTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGL 150
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 64 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 150
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 80
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 81 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 132
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 133 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 162
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 29/151 (19%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 32 MGEGSKGQMYRGRLKNGTF-IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCF 90
+G G G++Y G K + +A++ LK + + F+ ++ +++H +LV LG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC- 78
Query: 91 ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV 150
+ ++I E++ G L ++ Q + + A ++ +++L
Sbjct: 79 ------TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-- 130
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLL 181
+L + L+ +N + K++ + L L
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRL 160
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 62 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 37.4 bits (85), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/161 (24%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCLKMKKSHSTRNFMHHIELISKLRHCHL 82
+FD +G GS ++ RLK I A+R +K + + + I+ + +H
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED----IDWVQTEKHV-F 106
Query: 83 VSALGHCF-----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIG 137
A H F C+ + SR+F + EYV G L + + SA I
Sbjct: 107 EQASNHPFLVGLHSCF---QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 138 VARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+A + +LH G+ +LK+ ++LLD K++ Y +
Sbjct: 164 LA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM 199
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 37.4 bits (85), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 32/160 (20%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 22 ATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLR 78
+ NF +GEG+ G +Y+ R K G +A++ +++ + I L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 79 HCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
H ++V L + ++++L+FE++ + L+ ++ A + S +
Sbjct: 61 HPNIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+G+ F H+ V +LK ++L++ K++ + L
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 37.4 bits (85), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 40/185 (21%), Positives = 79/185 (42%), Gaps = 10/185 (5%)
Query: 20 EEATNNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHSTRNFMHHIELISKLR 78
+E +D +G G + R + G A++ +++ + + + ++ R
Sbjct: 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR-R 148
Query: 79 HCHLVSAL-GHCFECYFDDS--SVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAA 135
H++ + GH DS S S +FL+F+ + G L +++ S T+ I +
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 136 IGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVTPYS 195
+ A + FLH + +LK +ILLD N+ ++S + E EK+ +
Sbjct: 209 LLEA--VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP 263
Query: 196 GSINP 200
G + P
Sbjct: 264 GYLAP 268
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 38/162 (23%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 32 MGEGSKGQMYRGR-LKNGTFIAIR-CLKMKKSHSTRN----FMHHIELISKLRHCHLVSA 85
+G G G +++G + G I I C+K+ + S R H+ I L H H+V
Sbjct: 39 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFL 145
LG C S + L+ +Y+P G+L + H +L ++ + +A+G+ +L
Sbjct: 99 LGLC--------PGSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYL 149
Query: 146 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK 187
G+ NL ++LL +++ + + L +K
Sbjct: 150 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 188
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 36.6 bits (83), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 38/162 (23%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 32 MGEGSKGQMYRGR-LKNGTFIAIR-CLKMKKSHSTRN----FMHHIELISKLRHCHLVSA 85
+G G G +++G + G I I C+K+ + S R H+ I L H H+V
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFL 145
LG C S + L+ +Y+P G+L + H +L ++ + +A+G+ +L
Sbjct: 81 LGLC--------PGSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYL 131
Query: 146 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK 187
G+ NL ++LL +++ + + L +K
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 36.6 bits (83), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCLKMKKSHSTRNFMHHIELISKLRHCHL 82
+FD +G GS ++ RLK I A++ +K + + + I+ + +H
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED----IDWVQTEKHV-F 63
Query: 83 VSALGHCF-----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIG 137
A H F C+ + SR+F + EYV G L + + SA I
Sbjct: 64 EQASNHPFLVGLHSCF---QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 138 VARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+A + +LH G+ +LK+ ++LLD K++ Y +
Sbjct: 121 LA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM 156
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 36.2 bits (82), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A+ +++ + I L+ +L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 63 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 149
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 36.2 bits (82), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 32/158 (20%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLK-NGTFIAIRCLKMKKSHS--TRNFMHHIELISKLRHC 80
NF +GEG+ G +Y+ R K G +A+ +++ + I L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++V L + ++++L+FE++ + L+ ++ A + S + +
Sbjct: 62 NIVKLLDVI-------HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 36.2 bits (82), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCLKMKKSHSTRNFMHHIELISKLRHCHL 82
+FD +G GS ++ RLK I A++ +K + + + I+ + +H
Sbjct: 5 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED----IDWVQTEKHV-F 59
Query: 83 VSALGHCF-----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIG 137
A H F C+ + SR+F + EYV G L + + SA I
Sbjct: 60 EQASNHPFLVGLHSCF---QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 116
Query: 138 VARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+A + +LH G+ +LK+ ++LLD K++ Y +
Sbjct: 117 LA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM 152
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 35.8 bits (81), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRLKNGTFI-AIRCLKMKKSHSTRNFMHHIELISKLRHCHL 82
+FD +G GS ++ RLK I A++ +K + + + I+ + +H
Sbjct: 20 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED----IDWVQTEKHV-F 74
Query: 83 VSALGHCF-----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIG 137
A H F C+ + SR+F + EYV G L + + SA I
Sbjct: 75 EQASNHPFLVGLHSCF---QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 131
Query: 138 VARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+A + +LH G+ +LK+ ++LLD K++ Y +
Sbjct: 132 LA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM 167
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 35.8 bits (81), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 26/132 (19%), Positives = 59/132 (44%), Gaps = 9/132 (6%)
Query: 47 NGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIF 106
G +A++ L+ R+F I+++ L +V G + + L+
Sbjct: 35 TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY-----GPGRPELRLVM 89
Query: 107 EYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLD 166
EY+P+G LR ++ H + L ++ + + + +G+++L + +L +IL++
Sbjct: 90 EYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVE 145
Query: 167 QNLVAKISSYNL 178
KI+ + L
Sbjct: 146 SEAHVKIADFGL 157
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 35.4 bits (80), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNH 64
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 65 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 117 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 151
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 35.4 bits (80), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 64 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 35.4 bits (80), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 26/132 (19%), Positives = 59/132 (44%), Gaps = 9/132 (6%)
Query: 47 NGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIF 106
G +A++ L+ R+F I+++ L +V G + + L+
Sbjct: 38 TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY-----GPGRQSLRLVM 92
Query: 107 EYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLD 166
EY+P+G LR ++ H + L ++ + + + +G+++L + +L +IL++
Sbjct: 93 EYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVE 148
Query: 167 QNLVAKISSYNL 178
KI+ + L
Sbjct: 149 SEAHVKIADFGL 160
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 35.4 bits (80), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 26/132 (19%), Positives = 59/132 (44%), Gaps = 9/132 (6%)
Query: 47 NGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIF 106
G +A++ L+ R+F I+++ L +V G + + L+
Sbjct: 51 TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY-----GPGRQSLRLVM 105
Query: 107 EYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLD 166
EY+P+G LR ++ H + L ++ + + + +G+++L + +L +IL++
Sbjct: 106 EYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVE 161
Query: 167 QNLVAKISSYNL 178
KI+ + L
Sbjct: 162 SEAHVKIADFGL 173
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 35.4 bits (80), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 26/132 (19%), Positives = 59/132 (44%), Gaps = 9/132 (6%)
Query: 47 NGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIF 106
G +A++ L+ R+F I+++ L +V G + + L+
Sbjct: 39 TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY-----GPGRQSLRLVM 93
Query: 107 EYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLD 166
EY+P+G LR ++ H + L ++ + + + +G+++L + +L +IL++
Sbjct: 94 EYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVE 149
Query: 167 QNLVAKISSYNL 178
KI+ + L
Sbjct: 150 SEAHVKIADFGL 161
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 35.4 bits (80), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 33/168 (19%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G GS G +Y+G+ + + + + F + + ++ K RH +++ +G+
Sbjct: 20 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 76
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQRISAAIGVARGIQFLHTGIV 150
S+ ++ ++ ++ +L + HA ++ + I A ARG+ +LH
Sbjct: 77 -----STKPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLH---A 126
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVTPYSGSI 198
+ +LK +I L ++ KI + L + SGSI
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 35.4 bits (80), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 29/148 (19%), Positives = 66/148 (44%), Gaps = 14/148 (9%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G GS G +Y+G+ + + + + F + + ++ K RH +++ +G+
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 88
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQRISAAIGVARGIQFLHTGIV 150
S+ ++ ++ ++ +L + HA ++ + I A ARG+ +LH
Sbjct: 89 -----STAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNL 178
+ +LK +I L ++ KI + L
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGL 166
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 35.4 bits (80), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 64 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 35.4 bits (80), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 32 MGEGSKGQMYRG-RLKNGTFI----AIRCL-KMKKSHSTRNFMHHIELISKLRHCHLVSA 85
+G G+ G +Y+G + G + AI+ L + + FM +++ + H HLV
Sbjct: 23 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFL 145
LG C I L+ + +P+G L ++ H ++ ++ + +A+G+ +L
Sbjct: 83 LGVCLS--------PTIQLVTQLMPHGCLLEYVHEHK-DNIGSQLLLNWCVQIAKGMMYL 133
Query: 146 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK 187
+ +L ++L+ KI+ + L L E EK
Sbjct: 134 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 172
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 35.0 bits (79), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 32/168 (19%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G GS G +Y+G+ + + + + F + + ++ K RH +++ +G+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 72
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQRISAAIGVARGIQFLHTGIV 150
S+ ++ ++ ++ +L + H ++ + I A A+G+ +LH
Sbjct: 73 -----STAPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVTPYSGSI 198
+ +LK +I L ++L KI + L + SGSI
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 35.0 bits (79), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 36/176 (20%), Positives = 82/176 (46%), Gaps = 25/176 (14%)
Query: 24 NNFDTSAFMGEGSKGQMYRGRL----KNGTFIAIRCLK----MKKSHSTRNFMHHIELIS 75
NF+ +G G+ G+++ R G A++ LK ++K+ +T + +++
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 76 KLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQ-RISA 134
+R + L + F+ + +++ LI +Y+ G L + +S Q +T+ +
Sbjct: 114 HIRQSPFLVTLHYAFQ------TETKLHLILDYINGGELFTHLS----QRERFTEHEVQI 163
Query: 135 AIG-VARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL--PLLAENAEK 187
+G + ++ LH G+ ++K+ +ILLD N ++ + L +A+ E+
Sbjct: 164 YVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 35.0 bits (79), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 18/162 (11%)
Query: 32 MGEGSKGQMYRG-RLKNGTFI----AIRCL-KMKKSHSTRNFMHHIELISKLRHCHLVSA 85
+G G+ G +Y+G + G + AI+ L + + FM +++ + H HLV
Sbjct: 46 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 86 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFL 145
LG C I L+ + +P+G L ++ H ++ ++ + +A+G+ +L
Sbjct: 106 LGVCLS--------PTIQLVTQLMPHGCLLEYVHEHK-DNIGSQLLLNWCVQIAKGMMYL 156
Query: 146 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK 187
+ +L ++L+ KI+ + L L E EK
Sbjct: 157 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 195
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 35.0 bits (79), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 42/182 (23%), Positives = 80/182 (43%), Gaps = 22/182 (12%)
Query: 24 NNFDTSAFMGEGSKGQMYRGR-LKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHL 82
++F+ A +G+G+ GQ+ + R + + AI+ ++ + + + + L++ L H ++
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYV 64
Query: 83 VSALGHCFE------CYFDDSSVSRIFLIFEYVPNGTLRSWISG---HAWQSLTWT--QR 131
V E S +F+ EY NGTL I + + W ++
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 132 ISAAIGVARGIQFLHTGIVP-GVF---SNNLKITDILLDQNL-----VAKISSYNLPLLA 182
I A+ +H + P +F S N+KI D L +N+ + K+ S NLP +
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 183 EN 184
+N
Sbjct: 185 DN 186
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 35.0 bits (79), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 35/188 (18%), Positives = 76/188 (40%), Gaps = 14/188 (7%)
Query: 12 RTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHI 71
R S ++ E +G GS G +Y+G+ + + + + F + +
Sbjct: 24 RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 83
Query: 72 ELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQ 130
++ K RH +++ +G+ S+ ++ ++ ++ +L + H ++ +
Sbjct: 84 GVLRKTRHVNILLFMGY--------STKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIK 133
Query: 131 RISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGH 190
I A A+G+ +LH + +LK +I L ++L KI + L +
Sbjct: 134 LIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 190
Query: 191 VTPYSGSI 198
SGSI
Sbjct: 191 FEQLSGSI 198
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 34.7 bits (78), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 36/173 (20%), Positives = 74/173 (42%), Gaps = 16/173 (9%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRL-KNGTFIAIRCLKMKKS---HSTR 65
Y T + + N+ + MG G+ GQ+++ R K G IA++ +M++S +
Sbjct: 11 GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK--QMRRSGNKEENK 68
Query: 66 NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS 125
+ ++++ K C + CF + ++ V F+ E + GT +
Sbjct: 69 RILMDLDVVLKSHDCPYIV---QCFGTFITNTDV---FIAMELM--GTCAEKLKKRMQGP 120
Query: 126 LTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ +RI + VA + GV ++K ++ILLD+ K+ + +
Sbjct: 121 I--PERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 34.7 bits (78), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 35/188 (18%), Positives = 76/188 (40%), Gaps = 14/188 (7%)
Query: 12 RTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHI 71
R S ++ E +G GS G +Y+G+ + + + + F + +
Sbjct: 23 RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 82
Query: 72 ELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQ 130
++ K RH +++ +G+ S+ ++ ++ ++ +L + H ++ +
Sbjct: 83 GVLRKTRHVNILLFMGY--------STKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIK 132
Query: 131 RISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGH 190
I A A+G+ +LH + +LK +I L ++L KI + L +
Sbjct: 133 LIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 189
Query: 191 VTPYSGSI 198
SGSI
Sbjct: 190 FEQLSGSI 197
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 34.7 bits (78), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINAMLNH 64
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E ++ +FL EY G L I QR +
Sbjct: 65 ENVVKFYGHRRE-----GNIQYLFL--EYCSGGELFDRIEPDIGMPEPDAQRFFHQL--M 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 AGVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 151
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 34.7 bits (78), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 12/108 (11%)
Query: 71 IELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQ 130
IE + LRH H + L H E + ++IF++ EY P G L +I S T+
Sbjct: 59 IEALKNLRHQH-ICQLYHVLE------TANKIFMVLEYCPGGELFDYIISQDRLSEEETR 111
Query: 131 RISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+ I A + ++H+ G +LK ++L D+ K+ + L
Sbjct: 112 VVFRQIVSA--VAYVHSQ---GYAHRDLKPENLLFDEYHKLKLIDFGL 154
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 34.7 bits (78), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAAGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 64 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 34.7 bits (78), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 21/96 (21%), Positives = 45/96 (46%), Gaps = 11/96 (11%)
Query: 102 IFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQFLHTGIV--------PGV 153
++LI + G+L ++ G+ +TW + A ++RG+ +LH + P +
Sbjct: 88 LWLITAFHDKGSLTDYLKGNI---ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSI 144
Query: 154 FSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVG 189
+ K ++LL +L A ++ + L + E + G
Sbjct: 145 AHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPG 180
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 34.7 bits (78), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 29/148 (19%), Positives = 66/148 (44%), Gaps = 14/148 (9%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G GS G +Y+G+ + + + + F + + ++ K RH +++ +G+
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 88
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQRISAAIGVARGIQFLHTGIV 150
S+ ++ ++ ++ +L + HA ++ + I A ARG+ +LH
Sbjct: 89 -----STKPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNL 178
+ +LK +I L ++ KI + L
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGL 166
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 34.3 bits (77), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 32/168 (19%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G GS G +Y+G+ + + + + F + + ++ K RH +++ +G+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 72
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQRISAAIGVARGIQFLHTGIV 150
S+ ++ ++ ++ +L + H ++ + I A A+G+ +LH
Sbjct: 73 -----STKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVTPYSGSI 198
+ +LK +I L ++L KI + L + SGSI
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 34.3 bits (77), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 34/185 (18%), Positives = 75/185 (40%), Gaps = 14/185 (7%)
Query: 15 SLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELI 74
S ++ E +G GS G +Y+G+ + + + + F + + ++
Sbjct: 4 SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 75 SKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQRIS 133
K RH +++ +G+ S+ ++ ++ ++ +L + H ++ + I
Sbjct: 64 RKTRHVNILLFMGY--------STKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLID 113
Query: 134 AAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVTP 193
A A+G+ +LH + +LK +I L ++L KI + L +
Sbjct: 114 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 194 YSGSI 198
SGSI
Sbjct: 171 LSGSI 175
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 34.3 bits (77), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 65 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--M 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 AGVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 151
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 34.3 bits (77), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 65 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--M 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 AGVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 151
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 34.3 bits (77), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 34/185 (18%), Positives = 75/185 (40%), Gaps = 14/185 (7%)
Query: 15 SLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELI 74
S ++ E +G GS G +Y+G+ + + + + F + + ++
Sbjct: 4 SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 75 SKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQRIS 133
K RH +++ +G+ S+ ++ ++ ++ +L + H ++ + I
Sbjct: 64 RKTRHVNILLFMGY--------STKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLID 113
Query: 134 AAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVTP 193
A A+G+ +LH + +LK +I L ++L KI + L +
Sbjct: 114 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 194 YSGSI 198
SGSI
Sbjct: 171 LSGSI 175
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 34.3 bits (77), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 65 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--M 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 AGVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 151
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 34.3 bits (77), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E ++ +FL EY G L I QR +
Sbjct: 65 ENVVKFYGHRRE-----GNIQYLFL--EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 117 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 151
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 34.3 bits (77), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 64 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 34.3 bits (77), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 34/185 (18%), Positives = 75/185 (40%), Gaps = 14/185 (7%)
Query: 15 SLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELI 74
S ++ E +G GS G +Y+G+ + + + + F + + ++
Sbjct: 1 SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 75 SKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQRIS 133
K RH +++ +G+ S+ ++ ++ ++ +L + H ++ + I
Sbjct: 61 RKTRHVNILLFMGY--------STKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLID 110
Query: 134 AAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVTP 193
A A+G+ +LH + +LK +I L ++L KI + L +
Sbjct: 111 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 167
Query: 194 YSGSI 198
SGSI
Sbjct: 168 LSGSI 172
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 34.3 bits (77), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 65 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--M 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 AGVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 151
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 34.3 bits (77), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E ++ +FL EY G L I QR +
Sbjct: 64 ENVVKFYGHRRE-----GNIQYLFL--EYCSGGELFDRIEPDIGMPEPDAQRFFHQL--M 114
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 115 AGVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 34.3 bits (77), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 64 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 34.3 bits (77), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E ++ +FL EY G L I QR +
Sbjct: 64 ENVVKFYGHRRE-----GNIQYLFL--EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 34.3 bits (77), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E ++ +FL EY G L I QR +
Sbjct: 65 ENVVKFYGHRRE-----GNIQYLFL--EYCSGGELFDRIEPDIGMPEPDAQRFFHQL--M 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 AGVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 151
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 34.3 bits (77), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E +L EY G L I QR +
Sbjct: 64 ENVVKFYGHRREGNIQ-------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--M 114
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 115 AGVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 33.9 bits (76), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E ++ +FL EY G L I QR +
Sbjct: 63 ENVVKFYGHRRE-----GNIQYLFL--EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 114
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 115 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 149
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 33.9 bits (76), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E ++ +FL EY G L I QR +
Sbjct: 64 ENVVKFYGHRRE-----GNIQYLFL--EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 33.9 bits (76), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 29/147 (19%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRC----LKMKKSHSTRNFMHHIELISKLRHCHLVSALG 87
+G GS +Y+G T C K+ KS R F E + L+H ++V
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEXLKGLQHPNIVR--- 89
Query: 88 HCFECYFD--DSSVSR---IFLIFEYVPNGTLRSWISGHAWQSL----TWTQRISAAIGV 138
++D +S+V I L+ E +GTL++++ + +W ++I
Sbjct: 90 -----FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------ 138
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILL 165
+G+QFLHT P + +LK +I +
Sbjct: 139 LKGLQFLHTR-TPPIIHRDLKCDNIFI 164
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 33.9 bits (76), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 31/168 (18%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 12 RTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHI 71
R S ++ E +G GS G +Y+G+ + + + + F + +
Sbjct: 24 RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 83
Query: 72 ELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQ 130
++ K RH +++ +G+ S+ ++ ++ ++ +L + H ++ +
Sbjct: 84 GVLRKTRHVNILLFMGY--------STKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIK 133
Query: 131 RISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
I A A+G+ +LH + +LK +I L ++L KI + L
Sbjct: 134 LIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGL 178
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 33.9 bits (76), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E ++ +FL EY G L I QR +
Sbjct: 64 ENVVKFYGHRRE-----GNIQYLFL--EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 33.9 bits (76), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E ++ +FL EY G L I QR +
Sbjct: 64 ENVVKFYGHRRE-----GNIQYLFL--EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 33.9 bits (76), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 31/168 (18%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 12 RTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHI 71
R S ++ E +G GS G +Y+G+ + + + + F + +
Sbjct: 16 RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 75
Query: 72 ELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQ 130
++ K RH +++ +G+ S+ ++ ++ ++ +L + H ++ +
Sbjct: 76 GVLRKTRHVNILLFMGY--------STKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIK 125
Query: 131 RISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
I A A+G+ +LH + +LK +I L ++L KI + L
Sbjct: 126 LIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGL 170
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 33.9 bits (76), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 23 TNNFDTSAFMGEGSKG--QMYRGRLKNGTFIAIRCLKMKKS-HSTRNFMHHIELISKLRH 79
++D +GEG+ G Q+ R+ +A++ + MK++ N I + L H
Sbjct: 5 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 80 CHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVA 139
++V GH E ++ +FL EY G L I QR +
Sbjct: 64 ENVVKFYGHRRE-----GNIQYLFL--EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 115
Query: 140 RGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ +LH GI G+ ++K ++LLD+ KIS + L
Sbjct: 116 -GVVYLH-GI--GITHRDIKPENLLLDERDNLKISDFGL 150
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 33.9 bits (76), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 28/155 (18%), Positives = 68/155 (43%), Gaps = 15/155 (9%)
Query: 25 NFDTSAFMGEGSKGQMYRGR-LKNGTFIAIRCLKMKK--SHSTRNFMHHIELISKLRHCH 81
N+ +G+G+ ++ R + G +A++ + + S S + + ++ L H +
Sbjct: 8 NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 82 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARG 141
+V FE + + ++L+ EY G + ++ H W + + + +
Sbjct: 68 IVK----LFEVIETEKT---LYLVMEYASGGEVFDYLVAHGW--MKEKEARAKFRQIVSA 118
Query: 142 IQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
+Q+ H + +LK ++LLD ++ KI+ +
Sbjct: 119 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADF 150
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 33.9 bits (76), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 28/148 (18%), Positives = 66/148 (44%), Gaps = 14/148 (9%)
Query: 32 MGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGHCFE 91
+G GS G +Y+G+ + + + + F + + ++ K RH +++ +G+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 72
Query: 92 CYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQRISAAIGVARGIQFLHTGIV 150
S+ ++ ++ ++ +L + H ++ + I A A+G+ +LH
Sbjct: 73 -----STKPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 151 PGVFSNNLKITDILLDQNLVAKISSYNL 178
+ +LK +I L ++L KI + L
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGL 150
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 33.5 bits (75), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 32/171 (18%), Positives = 70/171 (40%), Gaps = 14/171 (8%)
Query: 29 SAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLVSALGH 88
S +G GS G +Y+G+ + I + + F + + ++ K RH +++ +G+
Sbjct: 41 STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 89 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQS-LTWTQRISAAIGVARGIQFLHT 147
+ + ++ ++ +L + H ++ Q I A A+G+ +LH
Sbjct: 101 M--------TKDNLAIVTQWCEGSSLYKHL--HVQETKFQMFQLIDIARQTAQGMDYLHA 150
Query: 148 GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVTPYSGSI 198
+ ++K +I L + L KI + L + V +GS+
Sbjct: 151 ---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 33.5 bits (75), Expect = 0.078, Method: Compositional matrix adjust.
Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 20/150 (13%)
Query: 10 AYRTFSLEELEEAT-NNFDTSAFMGEGSKGQMYRGRL------KNGTFIAIRCL-KMKKS 61
A +T S+ +L+E N +G G+ G++Y G++ + +A++ L ++
Sbjct: 30 AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE 89
Query: 62 HSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI--- 118
+F+ +ISKL H ++V +G + S+ R F++ E + G L+S++
Sbjct: 90 QDELDFLMEALIISKLNHQNIVRCIGVSLQ------SLPR-FILLELMAGGDLKSFLRET 142
Query: 119 --SGHAWQSLTWTQRISAAIGVARGIQFLH 146
SL + A +A G Q+L
Sbjct: 143 RPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 33.5 bits (75), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 20/150 (13%)
Query: 10 AYRTFSLEELEEAT-NNFDTSAFMGEGSKGQMYRGRL------KNGTFIAIRCL-KMKKS 61
A +T S+ +L+E N +G G+ G++Y G++ + +A++ L ++
Sbjct: 16 AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE 75
Query: 62 HSTRNFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI--- 118
+F+ +ISKL H ++V +G + S+ R F++ E + G L+S++
Sbjct: 76 QDELDFLMEALIISKLNHQNIVRCIGVSLQ------SLPR-FILLELMAGGDLKSFLRET 128
Query: 119 --SGHAWQSLTWTQRISAAIGVARGIQFLH 146
SL + A +A G Q+L
Sbjct: 129 RPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 33.5 bits (75), Expect = 0.090, Method: Compositional matrix adjust.
Identities = 36/157 (22%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 26 FDTSAFMGEGSKGQMYRGRLKN-GTFIAIRCLKMKKSHSTRNFMHHIELISKLRHC---H 81
FD +GEGS G +Y+ K G +AI+ + ++ + I+ IS ++ C H
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPH 85
Query: 82 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARG 141
+V G YF ++ ++++ EY G++ I ++LT + + +G
Sbjct: 86 VVKYYG----SYFKNTD---LWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKG 137
Query: 142 IQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
+++LH ++K +ILL+ AK++ + +
Sbjct: 138 LEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 32.3 bits (72), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 36/165 (21%), Positives = 68/165 (41%), Gaps = 16/165 (9%)
Query: 16 LEELEEATNNFDTSAFMGEGSKGQMYRGRLKNGTFIAIRCLKMKKSHST--RNFMHHIEL 73
L+E + + +G+G GQ+Y GR +AIR + +++ + + F +
Sbjct: 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 74 ISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRIS 133
+ RH ++V +G C S + +I TL S + A L +
Sbjct: 83 YRQTRHENVVLFMGACM-------SPPHLAIITSLCKGRTLYS-VVRDAKIVLDVNKTRQ 134
Query: 134 AAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
A + +G+ +LH G+ +LK ++ D V I+ + L
Sbjct: 135 IAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNGKVV-ITDFGL 175
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 32.3 bits (72), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 42/202 (20%), Positives = 89/202 (44%), Gaps = 38/202 (18%)
Query: 21 EATNNFDTSAFM---GEGSKGQMY--RGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELIS 75
+ TN T FM G G+ +++ + RL G A++C+K + + + I ++
Sbjct: 3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 76 KLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAA 135
K++H ++V+ L +E S + +L+ + V G L I +T++ ++
Sbjct: 62 KIKHENIVT-LEDIYE------STTHYYLVMQLVSGGELFDRILERG----VYTEKDASL 110
Query: 136 I--GVARGIQFLHTGIVPGVFSNNLKITDILL---DQNLVAKISSYNLPLLAEN------ 184
+ V +++LH G+ +LK ++L ++N I+ + L + +N
Sbjct: 111 VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA 167
Query: 185 -------AEKVGHVTPYSGSIN 199
A +V PYS +++
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVD 189
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 32.3 bits (72), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 41/181 (22%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 25 NFDTSAFMGEGSKGQMYRGR-LKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHLV 83
+F+ A +G+G+ GQ+ + R + + AI+ ++ + + + + L++ L H ++V
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVXLLASLNHQYVV 65
Query: 84 SALGHCFE--CYFDDSSV----SRIFLIFEYVPNGTLRSWISG---HAWQSLTWT--QRI 132
E + + S +F+ EY N TL I + + W ++I
Sbjct: 66 RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 133 SAAIGVARGIQFLHTGIVP-GVF---SNNLKITDILLDQNL-----VAKISSYNLPLLAE 183
A+ +H + P +F S N+KI D L +N+ + K+ S NLP ++
Sbjct: 126 LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 184 N 184
N
Sbjct: 186 N 186
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 32.0 bits (71), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 33/158 (20%), Positives = 65/158 (41%), Gaps = 15/158 (9%)
Query: 25 NFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMK---KSHSTRNFMHHIELISKLRHC 80
+F+ +G+GS G+ M R A++ LK + M +++
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++ L CF+ ++ R++ + EYV G L I + A +A
Sbjct: 81 PFLTQLHSCFQ------TMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAI 132
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ FL + G+ +LK+ +++LD KI+ + +
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 167
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 32.0 bits (71), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 41/182 (22%), Positives = 79/182 (43%), Gaps = 22/182 (12%)
Query: 24 NNFDTSAFMGEGSKGQMYRGR-LKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHL 82
++F+ A +G+G+ GQ+ + R + + AI+ ++ + + + + L++ L H ++
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYV 64
Query: 83 VSALGHCFE------CYFDDSSVSRIFLIFEYVPNGTLRSWISG---HAWQSLTWT--QR 131
V E S +F+ EY N TL I + + W ++
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 132 ISAAIGVARGIQFLHTGIVP-GVF---SNNLKITDILLDQNL-----VAKISSYNLPLLA 182
I A+ +H + P +F S N+KI D L +N+ + K+ S NLP +
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 183 EN 184
+N
Sbjct: 185 DN 186
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 30.8 bits (68), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 28/123 (22%), Positives = 59/123 (47%), Gaps = 16/123 (13%)
Query: 32 MGEGSKGQMYRG-RLKNGTF-------IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLV 83
+G+G+ ++++G R + G + + ++ L + + +F ++SKL H HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 84 SALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQ 143
G CF C D ++ L+ E+V G+L +++ + + ++ A +A +
Sbjct: 76 LNYGVCF-C--GDENI----LVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAWAMH 127
Query: 144 FLH 146
FL
Sbjct: 128 FLE 130
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 30.8 bits (68), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 33/158 (20%), Positives = 65/158 (41%), Gaps = 15/158 (9%)
Query: 25 NFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMK---KSHSTRNFMHHIELISKLRHC 80
+F+ +G+GS G+ M R A++ LK + M +++
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 81 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVAR 140
++ L CF+ ++ R++ + EYV G L I + A +A
Sbjct: 402 PFLTQLHSCFQ------TMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAI 453
Query: 141 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G+ FL + G+ +LK+ +++LD KI+ + +
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 488
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 30.0 bits (66), Expect = 1.00, Method: Compositional matrix adjust.
Identities = 19/60 (31%), Positives = 29/60 (48%), Gaps = 3/60 (5%)
Query: 119 SGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
G + +T IS + VARG++FL + +L +ILL +N V KI + L
Sbjct: 189 DGFYKEPITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGL 245
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 30.0 bits (66), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 137
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ K++ +
Sbjct: 138 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 29.6 bits (65), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 29/116 (25%), Positives = 47/116 (40%), Gaps = 14/116 (12%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHS 63
A F +E E A S +G+GS G +Y G K T +AI+ + S
Sbjct: 2 AADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 61
Query: 64 TR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 118
R F++ ++ + H+V LG S +I E + G L+S++
Sbjct: 62 ERIEFLNEASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYL 110
>pdb|2Z2E|A Chain A, Crystal Structure Of Canine Milk Lysozyme Stabilized
Against Non-Enzymatic Deamidation
pdb|2Z2E|B Chain B, Crystal Structure Of Canine Milk Lysozyme Stabilized
Against Non-Enzymatic Deamidation
Length = 129
Score = 29.3 bits (64), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 14/40 (35%), Positives = 23/40 (57%), Gaps = 3/40 (7%)
Query: 2 KLGALGLPAYRTFSLEE---LEEATNNFDTSAFMGEGSKG 38
KL ++G+ + +SL + E +NF+T AF G S+G
Sbjct: 11 KLKSMGMDGFHGYSLANWVCMAEYESNFNTQAFQGRQSQG 50
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 28.9 bits (63), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 34/160 (21%), Positives = 69/160 (43%), Gaps = 18/160 (11%)
Query: 24 NNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHL 82
+ F+ +G GS G+ M ++ G A++ L +K + H L +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEH------TLNEKRI 94
Query: 83 VSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
+ A+ F E F D+S ++++ EY P G + S + S + +A I +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNS--NLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
++LH+ + +LK ++++DQ K++ + L
Sbjct: 153 T--FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGL 187
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 28.9 bits (63), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 34 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 86
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 87 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 138
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 139 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 28.9 bits (63), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 34 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 86
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 87 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 138
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 139 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 28.9 bits (63), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 137
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 138 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 28.9 bits (63), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 137
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 138 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 28.9 bits (63), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 137
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 138 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 28.9 bits (63), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 19 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 71
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 72 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 123
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 124 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 171
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 28.9 bits (63), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 27/123 (21%), Positives = 58/123 (47%), Gaps = 16/123 (13%)
Query: 32 MGEGSKGQMYRG-RLKNGTF-------IAIRCLKMKKSHSTRNFMHHIELISKLRHCHLV 83
+G+G+ ++++G R + G + + ++ L + + +F ++SKL H HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 84 SALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGVARGIQ 143
G C C D ++ L+ E+V G+L +++ + + ++ A +A +
Sbjct: 76 LNYGVCV-C--GDENI----LVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMH 127
Query: 144 FLH 146
FL
Sbjct: 128 FLE 130
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 28.5 bits (62), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 36/184 (19%), Positives = 71/184 (38%), Gaps = 25/184 (13%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHS 63
A + +E E A S +G+GS G +Y G K T +AI+ + S
Sbjct: 11 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 64 TR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI---- 118
R F++ ++ + H+V LG S +I E + G L+S++
Sbjct: 71 ERIEFLNEASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYLRSLR 123
Query: 119 ----SGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 174
+ + ++ I A +A G+ +L+ +L + ++ ++ KI
Sbjct: 124 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 180
Query: 175 SYNL 178
+ +
Sbjct: 181 DFGM 184
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 28.5 bits (62), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 14/116 (12%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHS 63
A + +E E A S +G+GS G +Y G K T +AI+ + S
Sbjct: 1 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 60
Query: 64 TR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 118
R F++ ++ + H+V LG S +I E + G L+S++
Sbjct: 61 ERIEFLNEASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYL 109
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 28.5 bits (62), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 14/116 (12%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHS 63
A + +E E A S +G+GS G +Y G K T +AI+ + S
Sbjct: 4 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 63
Query: 64 TR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 118
R F++ ++ + H+V LG S +I E + G L+S++
Sbjct: 64 ERIEFLNEASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYL 112
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 28.5 bits (62), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EY+P G + S +
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYMPGGDMFSHLRRIGR 137
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ K++ +
Sbjct: 138 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 28.5 bits (62), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EY+P G + S +
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYMPGGDMFSHLRRIGR 137
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ K++ +
Sbjct: 138 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 28.5 bits (62), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 36/184 (19%), Positives = 71/184 (38%), Gaps = 25/184 (13%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHS 63
A + +E E A S +G+GS G +Y G K T +AI+ + S
Sbjct: 11 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 64 TR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI---- 118
R F++ ++ + H+V LG S +I E + G L+S++
Sbjct: 71 ERIEFLNEASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYLRSLR 123
Query: 119 ----SGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 174
+ + ++ I A +A G+ +L+ +L + ++ ++ KI
Sbjct: 124 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 180
Query: 175 SYNL 178
+ +
Sbjct: 181 DFGM 184
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 28.5 bits (62), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 14/116 (12%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHS 63
A + +E E A S +G+GS G +Y G K T +AI+ + S
Sbjct: 5 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 64
Query: 64 TR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 118
R F++ ++ + H+V LG S +I E + G L+S++
Sbjct: 65 ERIEFLNEASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYL 113
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 28.5 bits (62), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 14/116 (12%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHS 63
A + +E E A S +G+GS G +Y G K T +AI+ + S
Sbjct: 4 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 63
Query: 64 TR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 118
R F++ ++ + H+V LG S +I E + G L+S++
Sbjct: 64 ERIEFLNEASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYL 112
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 28.5 bits (62), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 14/116 (12%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHS 63
A + +E E A S +G+GS G +Y G K T +AI+ + S
Sbjct: 5 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 64
Query: 64 TR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 118
R F++ ++ + H+V LG S +I E + G L+S++
Sbjct: 65 ERIEFLNEASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYL 113
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 28.5 bits (62), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 14/116 (12%)
Query: 10 AYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHS 63
A + +E E A S +G+GS G +Y G K T +AI+ + S
Sbjct: 33 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 92
Query: 64 TR-NFMHHIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 118
R F++ ++ + H+V LG S +I E + G L+S++
Sbjct: 93 ERIEFLNEASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYL 141
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 28.1 bits (61), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 14/109 (12%)
Query: 17 EELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHSTR-NFMH 69
+E E A S +G+GS G +Y G K T +AI+ + S R F++
Sbjct: 5 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 70 HIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 118
++ + H+V LG S +I E + G L+S++
Sbjct: 65 EASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYL 106
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 28.1 bits (61), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 39/180 (21%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRS------- 116
H L ++ A+ F E F D+S ++++ EYVP G + S
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 137
Query: 117 WISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
+ HA R AA + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 138 FXEPHA--------RFYAA-QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 28.1 bits (61), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 14/109 (12%)
Query: 17 EELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHSTR-NFMH 69
+E E A S +G+GS G +Y G K T +AI+ + S R F++
Sbjct: 3 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 70 HIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 118
++ + H+V LG S +I E + G L+S++
Sbjct: 63 EASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYL 104
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 28.1 bits (61), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 39/180 (21%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRS------- 116
H L ++ A+ F E F D+S ++++ EYVP G + S
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 137
Query: 117 WISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
+ HA R AA + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 138 FXEPHA--------RFYAA-QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 28.1 bits (61), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 14/109 (12%)
Query: 17 EELEEATNNFDTSAFMGEGSKGQMYRGRLKN------GTFIAIRCLKMKKSHSTR-NFMH 69
+E E A S +G+GS G +Y G K T +AI+ + S R F++
Sbjct: 5 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 70 HIELISKLRHCHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 118
++ + H+V LG S +I E + G L+S++
Sbjct: 65 EASVMKEFNCHHVVRLLGVV-------SQGQPTLVIMELMTRGDLKSYL 106
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 28.1 bits (61), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 39/180 (21%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 34 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 86
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRS------- 116
H L ++ A+ F E F D+S ++++ EYVP G + S
Sbjct: 87 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 138
Query: 117 WISGHAWQSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
+ HA R AA + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 139 FXEPHA--------RFYAA-QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 27.7 bits (60), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 37/173 (21%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 34 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 86
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EY P G + S +
Sbjct: 87 EH------TLNEKRILQAVNFPFLTKLEFSFKDNS--NLYMVMEYAPGGEMFSHLRRIGR 138
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++++DQ K++ +
Sbjct: 139 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 27.7 bits (60), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 37/173 (21%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 34 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 86
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EY P G + S +
Sbjct: 87 EH------TLNEKRILQAVNFPFLTKLEFSFKDNS--NLYMVMEYAPGGEMFSHLRRIGR 138
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++++DQ K++ +
Sbjct: 139 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 27.7 bits (60), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 37/173 (21%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M ++ G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EY P G + S +
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYAPGGEMFSHLRRIGR 137
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++++DQ K++ +
Sbjct: 138 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 185
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 27.7 bits (60), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 33/160 (20%), Positives = 69/160 (43%), Gaps = 18/160 (11%)
Query: 24 NNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNFMHHIELISKLRHCHL 82
+ F+ +G GS G+ M ++ G A++ L +K + H L +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEH------TLNEKRI 94
Query: 83 VSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAWQSLTWTQRISAAIGV 138
+ A+ F E F D+S ++++ EY P G + S + S + +A I +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNS--NLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 139 ARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
++LH+ + +LK ++++DQ +++ + L
Sbjct: 153 T--FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGL 187
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 27.7 bits (60), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M + G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEYSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 137
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 138 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 27.7 bits (60), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M + G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEYSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 137
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 138 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 27.7 bits (60), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M + G A++ L +K +
Sbjct: 33 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQI 85
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 86 EH------TLNEKRILQAVNFPFLVKLEYSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 137
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 138 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 27.3 bits (59), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 38/175 (21%), Positives = 72/175 (41%), Gaps = 25/175 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M + G A++ L +K +
Sbjct: 54 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI 106
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 107 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 158
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 178
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 159 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF 208
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 27.3 bits (59), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQMYRGRLKN-GTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G++ + K G A++ L +K +
Sbjct: 26 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI 78
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 79 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 130
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 131 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 178
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 27.3 bits (59), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M + G A++ L +K +
Sbjct: 34 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI 86
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 87 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 138
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 139 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 26.9 bits (58), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M + G A++ L +K +
Sbjct: 34 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI 86
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 87 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 138
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 139 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 26.9 bits (58), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 9 PAYRTFSLEELEEATNNFDTSAFMGEGSKGQ-MYRGRLKNGTFIAIRCLKMKKSHSTRNF 67
PA T L++ E +G GS G+ M + G A++ L +K +
Sbjct: 34 PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQI 86
Query: 68 MHHIELISKLRHCHLVSALGHCF----ECYFDDSSVSRIFLIFEYVPNGTLRSWISGHAW 123
H L ++ A+ F E F D+S ++++ EYVP G + S +
Sbjct: 87 EH------TLNEKRILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVPGGEMFSHLRRIGR 138
Query: 124 QSLTWTQRISAAIGVARGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 176
S + +A I + ++LH+ + +LK ++L+DQ +++ +
Sbjct: 139 FSEPHARFYAAQIVLT--FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.322 0.135 0.411
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 6,290,021
Number of Sequences: 62578
Number of extensions: 248279
Number of successful extensions: 914
Number of sequences better than 100.0: 342
Number of HSP's better than 100.0 without gapping: 113
Number of HSP's successfully gapped in prelim test: 229
Number of HSP's that attempted gapping in prelim test: 707
Number of HSP's gapped (non-prelim): 342
length of query: 205
length of database: 14,973,337
effective HSP length: 94
effective length of query: 111
effective length of database: 9,091,005
effective search space: 1009101555
effective search space used: 1009101555
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 49 (23.5 bits)